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"Wie alles sich zum Ganzen webt, 
 Eins in dem andern wirkt und lebt!" 
Goethe (1749-1832), Faust I 
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1. Introduction 
 
1.1. Basic principles in immunity 
 
The mammalian immune system is a sophisticated network comprising 
a plethora of host factors and cells, which orchestrate a complex 
immune response upon pathogen invasion. Immune signaling can be 
generally divided into two distinct branches: the innate and the 
adaptive immune response. However, innate and adaptive immunity 
should not be considered as separate systems because the initial 
recognition of a pathogen by innate immune factors triggers a response 
that leads to the activation of adaptive immunity. Like gears in 
clockwork, innate and adaptive immunity intertwine to provide a fast 
and efficient protection against pathogen infection. 
 
1.1.1. Innate immunity 
 
The early phase of response against pathogens is controlled by the 
innate immune system, which is a universal and ancient form of host 
defense against infection. It includes a variety of defense strategies 
and is present at all times in the host. Innate immune responses are 
not specific to a particular pathogen but depend on a variety of 
molecules and phagocytic cells, including macrophages and 
neutrophiles, which recognize conserved molecular structures of 
microorganisms known as pathogen-associated molecular patterns 
(PAMPs) (Janeway Jr. and Medzhitov, 2002). PAMPs are sensed by a 
large superfamily of germline-encoded receptor proteins generally 
called pattern recognition receptors (PRRs). These receptors include 
Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), Nod-like 
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receptors (NLRs) and others (Melchjorsen, 2013). In addition, PRRs 
could recognize cell-derived danger-associated molecular patterns 
(DAMPs), which are expressed by an infected cell. Effective sensing of 
PAMPs and DAMPs rapidly induces host immune responses via 
complex intracellular signal transduction pathways that culminate in 
the expression of type I interferons (IFNs) and proinflammatory 
cytokines (Kawai and Akira, 2010; Medzhitov, 2007; Takeuchi and 
Akira, 2010). Cytokines are the key players in the immune response by 
modulating cell activation and differentiation and attracting immune 
cells to the sites of infection. Especially, type I IFNs and 
proinflammatory cytokines play a major role during infection by 
inducing the expression of numerous antiviral proteins (Takeuchi and 
Akira, 2010). 
 
1.1.2. Regulation of adaptive immunity by the innate immune 
response 
 
As mentioned above, the innate immune system is capable to mount an 
effective defense against infectious agents through the initiation of 
adaptive immunity. The adaptive immune response is mediated 
through the generation of antigen-specific B and T lymphocytes and 
provides long lasting protection against a pathogen by immunological 
memory (Hoebe et al., 2004; Iwasaki and Medzhitov, 2010).  
PRRs that recognize microbial pathogens are either expressed as 
transmembrane receptors (e.g. TLRs) or as cytosolic factors (e.g. 
RLRs). Most PRRs that are capable to activate the transcription 
factors NF-κB and IRFs are in principle able to induce T and B cell 
responses (Iwasaki and Medzhitov, 2004). However, the relative 
contribution of different PRRs to the induction of an adaptive immune 
response is not fully understood. 
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1.2. Pattern recognition receptors  
 
To date several families of PRRs (e.g. TLRs, RLRs, NLRs, and cytosolic 
DNA sensors) are known to play a crucial role in host defense 
mechanisms. This section gives a brief overview about recent advances 
in the field of PAMP recognition by PRRs and the signaling pathways 
activated thereby. 
 
1.2.1. Toll-like receptor (TLR) proteins 
 
TLRs are the best characterized PRRs and are considered to be the 
primary sensors of pathogens. In humans, 10 TLR family members 
have been identified since the discovery of toll proteins in flies in 1996 
(Lemaitre et al., 1996). TLRs belong to the family of type I membrane 
glycoproteins that consist of an extracellular leucine rich repeat (LRR) 
domain, which is required for PAMP recognition and a cytoplasmic 
Toll/interleukin-1 receptor (TIR) domain, responsible for downstream 
signaling (Kawai and Akira, 2011). TLRs are expressed on various 
immune cells including macrophages, dendritic cells, B and T 
lymphocytes, and even on non-immune cells like fibroblasts and 
epithelial cells. Expression of these receptors is modulated in response 
to pathogens and a variety of cytokines and may occur on extracellular 
or intracellular membranes.  
TLR 1, 2, 4, 5, and 6 are predominately expressed on the cell surface 
and recognize PAMPs of bacterial, fungal, and protozoal origin. In 
contrast, TLR 3, 7, and 9 are exclusively expressed on endocytic 
compartments recognizing nucleic acids derived from various bacteria 
and viruses. TLR 10 is not well characterized and its function remains 
unclear (Takeuchi and Akira, 2007; Kumar et al., 2009; Kawai and 
Akira, 2010).  
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Upon recognition of the respective PAMPs, TLRs dimerize and recruit 
TIR domain-containing adaptor molecules comprising MyD88, TIRAP, 
TRIF or TRAM. This recruitment initiates a downstream signaling 
Figure 1.1. TLR signaling in viral infection. Viral nucleic acids are recognized by TLR3 
(dsRNA), TLR7 (ssRNA, and TLR9 (vDNA) in endosomal compartments. Upon ligand binding, 
TLRs elicit a signaling cascade via TIR domain-containing adaptor molecules  (TRIF and 
MyD88) that leads to the activation of type I interferons and proinflammatory cytokines and 
finally to the induction of an antiviral state. 
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cascade that leads to the secretion of type-I IFNs, proinflammatory 
cytokines, and chemokines (Kawai and Akira, 2010). 
For example, intracellular TLRs transmit the initial signal to MyD88 
that recruits IRAK-1 and IRAK-4. These kinases phosphorylate the E3 
ubiquitin ligase TRAF6, which then activates NF-κB to initiate the 
expression of proinflammatory cytokines. In addition, IRAK-1 triggers 
the activation of IRF7, which induces the transcription and translation 
of type I IFNs  (Figure 1.1.) (Tseng et al., 2010). 
Activated TLR3 and TLR4 transduce the signal via a TRIF-dependent 
pathway, which is initiated through the recruitment of TRAF6 and 
RIP1. The interaction of TRAF6 with TRIF results in a signaling 
mechanism similar to the MyD88-dependent pathway. The interaction 
with RIP1 leads to K63-linked polyubiquitination of TRIF and to the 
recruitment of TBK1 and IKKε kinases that activate the transcription 
factor IRF3 and type I IFN expression (Figure 1.1.). 
 
1.2.2. Nucleotide-binding, oligomerization domain-like receptors 
(NLRs) 
 
 NLRs comprise a large group of multidomain proteins that contain a 
C-terminal LRR domain, a central nucleotide binding, oligomerization 
domain (NOD), and an N-terminal effector domain (Inohara and 
Nunez, 2001; Harton et al., 2002). NLRs can be grouped into 
subfamilies based on their effector domains (Ting et al., 2008). 
NOD1 and NOD2 are the best-studied members of the NLRC (NOD-
like receptor containing a CARD [caspase activation and recruitment 
domain]) family. These proteins are cytosolic receptors that recognize 
peptidoglycans of gram-positive and gram-negative bacteria. More 
recent studies revealed that NOD2 also recognizes viral ssRNA 
(Sabbah et al., 2009), demonstrating that these receptors trigger 
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innate immune responses upon sensing of a large variety of microbial 
pathogens. 
Upon binding of peptidoglycans to NOD1 and NOD2, the proteins 
oligomerize and transduce a signal via RIP2/NEMO(IKKγ) to activate 
NF-κB. In contrast, viral ssRNA recognition by NOD2 is RIP2-
independent and involves CARD-CARD interactions between the NLR 
and the mitochondrial antiviral signaling protein MAVS. This leads to 
the recruitment of numerous downstream factors and finally induces 
NF-κB and IRF signaling and the expression of proinflammatory 
cytokines and type I IFNs (Figure 1.2.) (Elinav et al., 2011). 
In contrast to NOD1 and NOD2, the NLR family members NLRP1 and 
NLRP3 (NOD-like receptor containing a PYD domain) assembles into 
large multiprotein complexes called inflammasomes, which are 
responsible for the activation of the inflammatory caspase-1. 
Currently, three different inflammasome complexes have been linked 
with antiviral signaling: the NLRP3-inflammasome (Kanneganti et al., 
2006; Allen et al., 2009; Ichinohe et al., 2009), the RIG-I inflammasome 
(Poeck et al., 2009), and the AIM2 inflammasome (Fernandes-
Alnemriet al., 2009; Hornung et al., 2009). 
Upon recognition of viral RNA NLRP3 associates with the apoptosis-
associated speck-like protein containing a CARD (ASC), which 
provides a link between the receptor and the pro-form of caspase-1. 
This interaction occurs through homotypic PYD and CARD 
interactions and leads to the activation of caspase-1. Activated 
caspase-1 cleaves pro-IL-1β and pro-IL-18 to release the biologically 
active forms, which become secreted to induce inflammation and 
antiviral responses (Figure 1.2.) (Dinarello et al., 1996 and 1998). 
  1. INTRODUCTION 
	  
  
  
7	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. NLR signaling and inflammasome formation in the context of viral infection. Left: 
MAVS-dependent signaling. NOD2-mediated sensing of ssRNA leads to the activation of 
MAVS and stimulate the transcription of type I interferons and proinflammatory cytokines. 
Right: Inflammasome-dependent signaling. Activation of NLRP3 and AIM2 results in the 
assembly of inflammasomes that activate caspase-1. Upon binding to ssRNA (NLRP3) or 
vDNA (AIM2) the proteins assemble into inflammsome complexes via an ASC-dependent 
mechanism. This leads to the activation of caspase-1 and to the processing of pro-IL-1β and 
pro-L-18.  
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1.2.3. Recognition of cytoplasmic DNA: AIM2 and other DNA sensors 
 
DNA that gains access to the cytosol is recognized by a variety of 
sensor molecules that initiate signaling responses to induce 
inflammatory molecules and immune factors. Endogenous DNA that is 
inappropriately cleared from the cytosol can induce chronic and 
pathological inflammation that result in autoimmune diseases like 
SLE  (systemic lupus erythematosus). In this section, the most 
common DNA sensors are outlined. 
a) The AIM2 inflammasome 
The PYHIN family protein AIM2 consists of an N-terminal PYD and a 
C-terminal HIN200 domain, which is responsible for DNA binding. 
Like NLRP1 and NLRP3, AIM2 activates caspases-1 via an ASC-
dependent mechanism. The sensor protein is localized in the cytosol 
and recognizes cytosolic DNA of viral origin (Fernandes-Alnemriet al., 
2009; Hornung et al., 2009). Upon DNA binding the AIM2 
inflammasome assembles around the DNA, which provides the scaffold 
for the multiprotein complex formation (Figure 1.2.) (Jin et al., 2012). 
The AIM2 inflammasome is essential for caspase-1 activation, but 
completely dispensable for type I IFN production in response to 
cytosolic dsDNA. This emphasizes the different roles of AIM2-mediated 
signaling and type I IFN production, which is largely dependent on 
STING (Barber, 2011).  
b) The cGAS-STING pathway 
Although the AIM2 response is important in host defense, the 
predominant response to cytosolic DNA is the induction of type I IFNs. 
A central molecule in this signal transduction cascade is the adaptor 
molecule STING, which is localized at the endoplasmatic reticulum 
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(ER) (Ishikawa and Barber, 2008; Jin et al., 2008; Zhong et al., 2008). 
Recent discoveries indicate that the nucleotidyl transferase cGAS 
produces the second messenger molecule cGAMP upon binding to 
cytosolic dsDNA (Civril et al., 2013; Gao et al., 2013; Kranzusch et al., 
2013; Wu et al., 2013). cGAMP is a cyclic molecule produced from ATP 
and GTP in the presence of DNA that binds to the adaptor molecule 
STING, facilitating its dimerization and activation and thereby 
triggering type I IFN expression upon TBK1 binding (Tanaka and 
Chen 2012). This recent finding provides new insight into the complex 
signaling pathways of DNA sensors. 
c) TLR9 and the detection of CpG DNA 
CpG DNA is a common feature of bacteria and viruses but it is absent 
in vertebrates (Hemmi et al., 2000). It is internalized via an endocytic 
pathway and traffics to lysosomal compartments were it associates 
with TLR9 (Sasai et al., 2010). Upon CpG DNA binding, TLR9 
interacts with MyD88 triggering the activation of IRF7 and NF-κB 
transcription factors (Iwasaki and Medzhitov, 2010).  
d) RNA Polymerase III detects cytosolic DNA and induces type I IFNs 
in a RIG-I-dependent pathway 
Transfection studies have identified RNA polymerase III as a novel 
DNA sensor that triggers a type I IFN response through the RIG-I 
signaling pathway (Ablasser et al., 2009; Chiu et al., 2009). It was 
shown that transfected poly(dA/dT) dsDNA served as a template for 
RNA polymerase III, which was then transcribed into A/U-rich dsRNA 
containing 5’triphosphate moieties. Activation of RIG-I by this dsRNA 
induces a potent type I IFN response and activation of transcription 
factor NF-κB. The utilization of RNA polymerase III as a DNA sensor 
for bacteria and DNA viruses may therefore allow the host to take 
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advantage of the RIG-I signaling pathway to defend against a large 
variety of microbial pathogens. However, the physiological relevance of 
this pathway still needs to be clarified. 
 
  
1.3. RIG-I-like receptor (RLR) proteins 
 
1.3.1. RLRs are superfamily 2 DExD/H-box helicases 
 
The retinoic acid inducible gene I (RIG-I)-like receptor (RLR) proteins  
are key players in innate immunity and act by recognizing viral RNA 
(vRNA) in the cytosol. The RLR family consists of the members RIG-I 
(retinoic acid inducible gene I), MDA5 (melanoma differentiation 
associated protein 5), and LGP2 (laboratory of genetics and physiology 
2) (Yoneyama et al., 2004; Kato et al., 2011; Loo and Gale Jr. 2011). 
RLRs are DExD/H-box helicase-like proteins sharing a central ATP-
dependent helicase domain and a C-terminal regulatory domain (RD) 
that is responsible for initial RNA binding. In addition, RIG-I and 
MDA5 possess N-terminal tandem CARDs that are responsible for 
downstream signaling (Figure 1.3.) (Yoneyama et al., 2004; Fujita et 
al., 2007; Wang et al., 2010). 
 
 
 
 
 
 
 
Figure 1.3. RLR structural architecture (Loo and Gale Jr., 2011). 
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Several crystal structures of RIG-I have shown that in the absence of 
virus, the protein exists in an auto-inhibited state, where the CARDs 
are sterically unavailable for signal transduction (Civril et al., 2011; 
Kowalinski et al., 2011; Ferrage et al., 2012). Upon viral infection and 
initial vRNA binding, the protein undergoes large conformational 
changes driven by ATP hydrolysis, leading to the exposure of CARDs 
to the cytosol. Lysine residues of the CARD2 domain are now available 
for polyubiquitination by the E3 ubiquitin ligase TRIM25 (Gack et al., 
2007; Zeng et al., 2010), which is thought to trigger the interaction 
with the adaptor protein MAVS in the mitochondrial membrane. 
In contrast to RIG-I, MDA5 does not exist in an auto-inhibited state 
but is rather thought to adopt an open conformation in the absence of 
vRNA (Berke and Modis, 2012). Upon dsRNA binding, the helicase 
domain of MDA5 forms a ring-like structure around the phosphate 
backbone of the ligand, which exhibits a more open conformation in 
comparison to RIG-I (Wu et al., 2013). 
The RD domains between RLR proteins reveal differences that provide 
the molecular basis for recognition of distinct RNA structures. While 
the RIG-I RD comprises a pocket for the binding of 5’ triphosphate 
containing blunt-ended dsRNA (Leung and Amarasinghe, 2012), the 
flat surface of the MDA5 RD rather allows stem loop recognition of 
dsRNA (Wu et al., 2013).  
Structural and biophysical analyses support a model, in which MDA5 
cooperatively forms ATP-sensitive filaments upon binding to long 
dsRNA molecules (Peisley et al., 2011; Berke et al., 2012; Berke and 
Modis, 2012; Wu et al., 2013). This is a remarkable difference in regard 
to RIG-I, which is thought to form monomeric or dimeric signaling 
complexes upon binding to blunt ended 5’ triphosphate dsRNA (Cui et 
al., 2008; Kohlway et al., 2013). However, recent data suggest that 
RIG-I forms ATP hydrolysis-driven filaments that propagate from the 
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dsRNA blunt end to the interior of the molecule (Patel et al., 2013; 
Peisley et al., 2013). These recent findings require further analyses to 
investigate the exact mode of ATP hydrolysis by RLR proteins and its 
role in filament formation. 
In contrast to RIG-I and MDA5, the role of LGP2 in cytosolic RNA 
sensing remains unclear. Some reports suggest that LGP2 is required 
for type I IFN production to some RIG-I- and MDA-dependent viruses, 
whereas others describe LGP2 as a negative regulator for RIG-I-
dependent signaling (Bruns and Horvath, 2012). 
 
1.3.2. RLR signal transduction via MAVS 
 
Activated RIG-I and MDA5 transmit the initial signal to the 
downstream signaling pathway by binding to MAVS through 
homotypic CARD-CARD interactions (Takeuchi and Akira, 2010). In 
recent studies it has been suggested that the engagement of MAVS by 
RLRs, triggers the formation of large aggregates of the protein at the 
mitochondrial membrane (Hioscott et al., 2006; Ohmann et al., 2009; 
Dixit et al., 2010; Hou et al., 2011). The assembly of such 
“signalosomes” results in a large scale amplification of the signaling 
cascade and allows for highly sensitive detection of very small amounts 
of viral RNA that then induce the antiviral response (Zeng et al., 
2010). 
Formation of the MAVS “signalosome” triggers the recruitment of 
numerous downstream signaling factors (Figure 1.4.) including tumor 
necrosis factor receptor (TNFR)-associated death domain (TRADD) 
protein, which exists in complex with Fas-associated death domain-
containig (FADD) protein and the death domain kinase RIP1. 
Signaling to this complex results in the recruitment and activation of 
TANK, NAP1 and NEMO to facilitate the activation of IRF3 and IRF7 
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by the kinases TBK1 and IKKε (Loo and Gale Jr., 2011). In addition, 
TANK and NAP1 recruit the kinases IKKα, β, and γ leading to the 
a
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i
v
a
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o
n 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. RLR signaling pathway. Upon binding to its respective RNA ligands, RIG-I and 
MDA5 become activated and transmit the signal via direct CARD-CARD interaction to MAVS, 
which is located in the mitochondrial membrane. Activation of MAVS triggers the formation of 
a “signalosome” complex by recruiting numerous downstream signaling factors including 
protein kinases and ubiquitin ligases. Finally, IRFs and NF-κB induces the expression of type 
I interferons and proinflammatory cytokines. 
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activation of NF-κB-dependent expression of proinflammatory 
cytokines (Figure 1.4.). Furthermore, the E3 ubiquitin ligase TRAF6, 
which binds to the TRAF-interracting motif (TIM) in the proline-rich 
region of MAVS, facilitates the recruitment of IKKε kinase to the 
signalosome, thereby enhancing the IRF-3-dependent induction of type 
I IFN gene expression (Haecker et al., 2006; Oganesyan et al., 2006). 
Taken together, RLR signaling is regulated through multiple steps 
including posttranslational modifications like polyubiquitination and 
phosphorylation. This complexity in the signaling pathway may serve 
to fine-tune the RLR response to specific pathogenic stimuli. 
 
1.3.3. Preferential roles of RLRs for virus recognition  
 
In vitro studies revealed that most RNA viruses with a non-segmented 
negative-strand RNA genome, including measles virus (MeV), rabies 
virus (RABV), and Sendai virus (SeV) are preferentially recognized by 
RIG-I (Plumet et al., 2007; Loo et al., 2008). In contrast MDA5, 
preferentially senses picornaviruses with a positive-strand RNA 
genome (Loo et al., 2008). However, the observed preferences are 
unlikely to be exclusive. In case of MDA5, a minor contribution to 
recognition of MeV and SeV has been reported (Yount et al., 2008; 
Ikegame et al., 2010). 
 
1.3.4. RNA structures recognized by RLRs 
 
The viral specificity of RLRs emphasizes their remarkable capability to 
detect RNAs that are only present in infected cells. How RLRs actually 
discriminate between self and non-self RNA is not fully understood. 
Several in vitro studies report that RIG-I preferentially binds 5’ 
triphosphate containing blunt-ended RNA with double-stranded 
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regions (Hornung et al., 2006; Pichlmair et al., 2006; Schlee et al., 
2009; Schidt et al., 2009). Consistent with this, viral 5’ triphosphate 
containing dsRNA was identified as the physiological RIG-I agonist in 
cells infected with influenza and SeV (Baum et al., 2010; Rehwinkel et 
al., 2010; Weber et al., 2013). Recently, it was shown that 5’ 
triphosphate containing RNA is not the only ligand for RIG-I. Specific 
U/C-rich regions within certain viral genomes seem to contribute to 
efficient recognition by the protein (Saito et al., 2008; Schnell et al., 
2012). 
In contrast to RIG-I agonists, MDA5 ligands from virus-infected cells 
are not as well understood. Since picornaviruses are preferably sensed 
by MDA5 (Weber et al., 2006; Pichlmair et al., 2009), it was speculated 
that the protein could act as a simple dsRNA sensor in the cytosol. 
Consistent with this model it was shown that MDA5 becomes activated 
upon binding to poly (I/C) RNA, which is a synthetic analog of dsRNA 
(Takeuchi and Akira et al., 2010). Furthermore, it was suggested that 
MDA5 predominantly binds to long dsRNA stretches, while RIG-I is 
responsible for recognition of RNAs with short double-stranded regions 
(Kato et al., 2008). However, the precise nature of MDA5 agonists in 
infected cells might actually be more complex than dsRNA and could 
comprise structures or sequences that occur in the cytosol in the course 
of viral infection. For example, data on the enzyme RNase L suggest 
that small RNA cleavage products from the enzyme fold into RIG-I and 
MDA5 agonists containing 5’ hydroxyl groups and 3’ monophosphate 
moieties that efficiently activate the RLR signaling response (Malahti 
et al., 2007; Malathi et al., 2010; Luthra et al., 2011). In light of the 
divergent data, further work will be required to characterize naturally 
occurring RLR agonists. 
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1.4. Interplay between Mononegavirales and the innate 
immune system 
 
 Among viruses with RNA genomes, the order of negative-single-strand 
viruses (Mononegavirales) comprises many human pathogens causing 
severe diseases, like measles virus (MeV), rabies virus (RABV), Sendai 
virus (SeV), and Ebola virus (EBOV). These viruses replicate in the 
cytosol and use nucleoprotein complexes or nucleocapsids as 
replication templates instead of naked RNA (Gerlier and Lyles, 2011). 
 
1.4.1. Virus replication cycle 
 
 Mononegavirales are enveloped viruses that share many common 
features and their genome organization is well conserved throughout 
this virus order. For example, the MeV genome consists of 15894 
nucleotides encoding for 6 genes that are arranged in 3’ to 5’ direction 
(Figure 1.5.). The genes encode for a nucleoprotein (N), a 
phosphoprotein (P) and two non-structural proteins (V, C), a matrix 
protein (M), a fusion protein (F), a hemaglutinin protein (H), and a 
large RNA-dependent RNA polymerase (L). The P gene gives rise to 3 
proteins (P, V, and C) through RNA editing (Lamb and Parks, 2007). 
The MeV genome is flanked by two small non-coding RNA sequences 
serving as promoter regions for replication and transcription: the 
leader (leRNA) and trailer (trRNA) regions. 
 Upon viral entry into the cell, the incoming P+L polymerase complex 
starts immediately to transcribe all genes from the genomic RNA of 
negative polarity (Lamb and Parks, 2007). The transcripts from every 
gene are 5’ capped and polyadenylated by the polymerase. By arriving 
at an intergenic junction, the transcriptase either resumes RNA 
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synthesis at the next downstream gene or reinitiates upstream 
transcription, resulting in an mRNA gradient declining from 3’ to 5’ 
direction (Figure 1.5. A) (Cattaneo et al., 1987). New P+L 
transcriptases accumulate and enhance the transcription until enough 
N protein is synthesized. At this state, the virus switches from 
transcription to replication with a replicase complex consisting of N, P, 
and L proteins. The replication consists of an uninterrupted synthesis 
of the complementary antigenome, which is concurrently encapsidated 
by N proteins to form the so-called nucleocapsids (NCs). The new 
antigenomic NC serves as a template for the synthesis of genomic 
RNA, which is also immediately encapsidated into NCs. Consequently, 
the genome and antigenome do not exist naked in the infected cells 
and cannot anneal to each other or to viral transcripts (Gerlier and 
Lyles, 2011).  
 
1.4.2. Viral RLR agonists from Mononegavirales: Towards a rational 
model. 
  
 Numerous in vitro studies focused on the nature of RLR agonists 
(Hornung et al., 2006; Pichlmair et al., 2006; Schlee et al., 2009; Schidt 
et al., 2009).  It is now widely accepted in the field that the preferred 
RIG-I ligand is a 5’ triphosphate containing dsRNA molecule. However 
it should be noted, that most of these in vitro data depend on 
transfection of RNAs extracted from virions or virally infected cells, 
which only provide limited or even misleading information about the 
physiological RIG-I agonist. In fact, these experiments were performed 
with extracted, denatured and purified RNA molecules comprising 
negative and positive RNA strands that could easily anneal to each 
other into dsRNA in the absence of N protein, which may never exist in 
an infected cell (Gerlier and Lyles, 2011). Therefore, the following 
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section will discuss the occurrence of viral RNA species in infected cells 
and their putative role as RLR agonists.  
 As already discussed in section 1.4.1., the genomic and antigenomic 
replication products from Mononegavirales do not exist as naked RNAs 
in the cytolsol, but are tightly packed into NC particles, in which the 
RNA is largely inaccessible. Biochemical experiments showed that 
RNA is resistant to nuclease degradation and RNA interference within 
these complexes (Blumberg et al., 1981; Bitko and Barik, 2001;Reuter 
et al., 2006; Mottet-Osmann et al., 2007). Therefore, the viral genome 
and antigenome should not be considered as putative RLR agonists. 
However, the viral replication machinery is rather imprecise giving 
rise to abortive 5’ genomes and antigenomes, which are not properly 
packed into NC particles (Figure 1.5. B). Furthermore, replication 
results in nucleocapsids with large internal deletions, called defective 
interfering (DI) particles, which may also fail to be correctly 
encapsidated. Upon self-hybridization into panhandle RNA structures, 
or upon genome-antigenome hybridization, these RNA species could 
make 5’ triphosphate containg blunt-ended dsRNAs (Strähle et al., 
2006). Indeed, a recent study on SeV-infected cells proposed a 546-nt-
long copy-back DI particle encompassing the end of the L gene and 
trRNAs as a ligand for RIG-I (Baum et al., 2010). Furthermore, read-
through L-trRNA mRNA could potentially hybridize to 5’ triphosphate 
containing trRNA, which is then recognized by the receptor protein as 
an intermolecular dsRNA (Figure 1.5. B). It should be noted that in 
contrast to (+) RNA viruses (e.g. picornaviruses), (-) RNA viruses 
generate only short dsRNA species (Weber et al., 2006). This 
observation may provide a possible explanantion for the minor 
contribution of MDA5 to (-) RNA virus recognition (Yount et al., 2008; 
Ikegame et al., 2010). 
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Beside trRNA, the leRNA transcripts are possible candidates for 5’ 
triphosphate containing RIG-I ligands. However, it has been reported 
that these RNA molecules only exist in very limited amounts in 
infected cells, likely because of a lack in stability (Leppert et al., 1979; 
Vidal and Kolakofsky, 1989).  
Finally, kinetic investigations on MeV-infected cells indicate that IFN-
β expression strongly correlates with virus transcription (Plumet et al., 
2007). However, fully transcribed mRNA molecules should not be 
considered as RLR agonists, since these species are subsequently 
capped, 5’ O methylated, and polyadenylated by the viral polymerase 
Figure 1.5. Viral RNA species and genomic organization of measles virus. (A) Viral mRNA 
gradient generated in the course of sequential transcription by the P+L transcriptase. In case 
of the antigenome only the trRNA is transcribed. With the exception of leRNA and trRNA, all 
transcripts are readily capped, ribose-O-methylated and polyadenylated. The replicase 
complex N+P+L carries out RNA replication. It consists of an uninterrupted synthesis of the 
genome and antigenome, which is readily packed into nucleocapsids by the N protein. (B) 
Potential RLR agonists due to transcriptase or replicase errors (adapted and modified from 
Gerlier and Lyles, 2011). 
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and exhibit exact the same characteristics as endogenous mRNA 
(Figure 1.5. A) (Li et al., 2009; Rahmeh et al., 2009). In this context it 
should be emphasized, that transcription also gives rise to non-
functional byproducts. Read-through transcripts occur at frequencies of 
a few percent, resulting in bi- or tri-cristronic RNAs. Furthermore, 5’ 
triphosphorylated leader-N and L-antitrailer RNAs are transcribed 
(Cattaneo et al., 1987) (Figure 1.5. B), that may explain the 
correlation of type I IFN production and virus replication (Plumet et 
al., 2007). 
According, to the complex RNA composition in a virus-infected cell, the 
prediction of putative RNA ligands is challenging and further in vivo 
investigations are required to clarify, which RNAs are recognized by 
RLR proteins under physiological conditions. 
 
 
1.5. Viral evasion of type I IFN signaling  
 
The type I IFN system mediates a broad variety of antiviral effects. 
Consequently, successful viruses have been evolutionary selected to 
develop countermeasures to circumvent the IFN response. For 
example, the Mononegavirales can either mask the RNA structures 
that are recognized by RLRs or minimize their production (Vidal and 
Kolakofsky, 1983; Manuse and Parks, 2009). As discussed in section 
1.4.2., the encapsidation of viral genome and antigenome into NCs 
efficiently prevent dsRNA formation and RLR recognition. 
Paramyxovirus C proteins and the RSV (Respiratory syncytial virus) 
NS1 protein negatively regulate the viral transcription rate, thereby 
limiting the production of putative RLR agonists (Cadd et al., 1996; 
Atreya et al., 1998; Baron and Barrett, 2000). The polymerase subunit 
VP35 of Ebola virus was shown to bind to dsRNA, which thereby 
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sequesters the molecule from the cytosol and from recognition by the 
immune receptors (Cardenas et al., 2006). 
Furthermore, viruses encode for numerous proteins that directly target 
RNA sensors or their downstream signaling, thereby efficiently 
interfering with the antiviral immune response (Gerlier and Lyles, 
2011; Taylor and Mossmann, 2012). Members of the paramyxovirus 
family (e.g. measles, parainfluenza, and Sendai virus) encode for V 
proteins that interfere with type I IFN expression by targeting MDA5, 
LGP2, and NF-κB (Childs et al., 2007; Schumann et al., 2011). Measles 
virus V protein was also shown to bind to JAK1 interfering with 
STAT1 phosphorylation (Caignard et al., 2007). By determining the 
structure of MDA5 in complex with parainfluenza virus V protein, the 
inhibitory mechanism has been previously elucidated. Upon binding to 
MDA5, the viral protein unfolds the ATPase domain via a β-hairpin 
motif that consequently leads to the disruption of the MDA5 ATP 
hydrolysis site and prevents RNA bound filament formation (Motz et 
al., 2013). The high efficiency of MDA5 inhibition by the V protein may 
explain the low contribution of MDA5 in mediating the activation of 
type I IFNs in response to paramyxoviruses (Gitlin et al., 2010; 
Ikegame et al., 2010). 
Besides the direct inhibition of RLRs, viral proteins interfere with the 
immune response by disrupting the downstream signaling cascade. C 
proteins from RPV (Rinder pest virus), MeV and SeV inhibit the 
activation of the IFN-β gene downstream of the phosphorylation and 
dimerization of IRF3, suggesting a nuclear mode of action (Shaffer et 
al., 2003; Strähle et al., 2007; Boxer et al., 2009; Sparrer et al., 2012). 
Rubaluvirus V protein, RABV P protein, and filovirus VP35 were also 
shown to inhibit IFN-β production by preventing IRF3 phosphorylation 
via TBK-1 and IKKε (Brzozka et al., 2005; Lu et al., 2008; Prins et al., 
2009). 
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Efficient RIG-I inhibitors include the NS2 protein of RSV, which binds 
to the N-terminal CARD of RIG-I, thereby preventing the recruitment 
of MAVS by competition (Ling et al., 2009). The HIV (Human 
immunodeficiency virus) protease decreases cytoplasmic RIG-I levels 
by targeting the protein to the lysosome (Solis et al., 2011). 
The list of additional viral evasion factors and their distinct 
mechanisms of interfering with the immune system is long. However, 
these few examples already give insights into the impressive diversity 
of tactics, viruses have developed to escape from the antiviral cellular 
system. 
 
 
1.6. Objectives of the thesis 
 
As discussed above, many studies focused on the identification of RNA 
agonists for RLR proteins (Hornung et al., 2006; Pichlmair et al., 2006; 
Weber et al., 2006; Saito et al., 2008; Schlee et al., 2009; Schmidt et al., 
2009; Pichlmair et al., 2009; Baum et al., 2010; Rehwinkel et al., 2010; 
Schnell et al., 2012; Weber et al., 2013). However, these studies largely 
relied on in vitro experiments that may result in misleading or even 
false interpretation. To elucidate the exact nature and origin of viral 
RLR agonists it is therefore indispensable to isolate and investigate 
RLR-associated RNA from virus-infected cells. Recent studies on SeV-
infected cells identified SeV DI particles as potent RIG-I inducers 
(Baum et al., 2010). However the physiological ligand for MDA5 and 
LGP2 still needs to be investigated. A major challenge in regard to 
examining MDA5 agonists is the apparently transient interaction 
between the protein and its RNA ligand, making common pull down 
approaches inadequate for studying MDA5-associated RNA. 
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To improve the stability of interaction between MDA5 and its RNA 
ligand a crosslinking approach was established in the lab, adopted 
from the PAR-CLIP (Photoactivatable-Ribonucleoside-Enhanced 
Crosslinking and Immunoprecipitation) methodology (Hafner et al., 
2010) (Figure 1.6.). In this approach, virus-infected cells are treated 
with the photoactivatable nucleoside analog 4-thiouridine (4SU) 
(Figure 1.7.), which is then incorporated into newly synthesized viral 
RNA. Upon 365 nm UV exposure of living cells, a covalent linkage 
between the 4SU-labeled RNA and the receptor protein is induced. 
Figure 1.7. Examples of photoactivatable 
nucleoside analogs (Hafner et al., 2010) 
Figure 1.6. PAR-CLIP methodology. Cells expressing the RNA-binding protein (RBP) of 
interest are treated with 4SU. 24 h later, cells are in vivo crosslinked with 365 nm UV. The 
cells are harvested and lyzed and the respective proteins are immunprecipitated. cDNA 
libraries can be generated from the isolated co-purified RNA and subjected to Next generation 
sequencing. (Hafner et al., 2010). 
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This leads to a higher RNA recovery from RLR immunoprecipitates 
and facilitates the analysis of putative RLR agonists. 
To shed light on the nature of physiological RLR ligands in an 
unbiased manner, the crosslinking approach was combined with Next 
generation sequencing (NGS) analysis. Additional biochemical 
experiments were performed to independently validate the obtained 
results. 
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2.  Material & Methods 
 
2.1.  Material 
 
2.1.1. Chemicals 
 
All chemicals used in this thesis were purchased from Roth (Karlsruhe, 
Germany) and Sigma (Deisenhofen, Germany) unless otherwise stated. 
Mammalian cell culture media and reagents were purchased from 
Invitrogen, Life Technologies (Grand Island, NY, USA).  
Reagents and siRNAs for RNA biology were obtained from Ambion, 
Life Technologies.  
Enzymes and nucleotides for molecular biology were supplied by MBI 
Fermentas (St. Leon-Rot, Germany) or New England Biolabs (Ipswich, 
MA, USA).   
For deep sequencing analysis reagents and kits were supplied by 
Illumina (San Diego, CA, USA) and Epicentre Biotechnologies 
(Madison, WI, USA).  
Reagents for quantitative PCR analysis were purchased from Roche 
Diagnostics (Mannheim, Germany).  
Primary antibodies to human MDA5 (AT113) and RIG-I (Alme-1) were 
purchased from Enzo Life Science (Loerrach, Germany). Antibody to 
GFP (ab1218) and monoclonal anti-β tubulin (TUB 2.1) were obtained 
from Abcam (Cambridge, UK) and Sigma, respectively. Antibodies to 
actin and measles P and N proteins were kindly provided by Prof. Dr. 
Karl-Klaus Conzelmann (LMU, Munich). Secondary antibodies were 
supplied by GE Healthcare (Buckinghamshire, UK). 
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2.1.2. Viral strains 
 
Sendai virus Cantell (SeV-C) and Encephalomycarditis virus (EMCV) 
were generously provided by Prof. Dr. Adolfo Garcia-Sastrè (Mount 
Sinai Hospital, New York). Measles and rabies strains were obtained 
by Prof. Dr. Karl-Klaus Conzelmann. Mengo virus was provided by PD 
Dr. Anne Krug (TU Muenchen, Munich). 
 
2.1.3. Mammamlian cell lines 
  
In this thesis two human cell lines were used for the infection 
experiments. A549 human lung carcinoma cell lines were used for 
infection experiments and for the investigation of natural RNA ligands 
for RLR proteins. The cells were kindly provided by Prof. Dr. Karl-
Klaus Conzelmann. 
For immunostimulatory experiments human embryonic kidney (HEK) 
293T ISRE FF/RFP cell lines were used. These cells stably integrated 
an interferon-stimulated response element (ISRE) in the genome, 
controlling the expression of the reporter genes firefly luciferase and 
RFP. The cells are a gift from Prof. Dr. Adolfo Garcia-Sastrè. 
 
2.1.4.  Mammalian cell culture 
 
Cell lines were cultured in complete growth media and grown in a 
humidified, 37 ºC, 5% CO2 incubator. When cells reached a confluency 
of approx. 80%, the medium was removed and cells were washed with 
PBS. Cells were detached by trypsin (EDTA) solution (Invitrogen) and 
diluted to the desired concentration in complete growth media. 
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Buffer 
Composition 
Complete growth medium DMEM, 10% FBS, 2 mM L-glutamine,  
1% Penicilin/Streptavidin solution 
PBS 10 mM phosphate, 137 mM NaCl, 2.7 mM 
KCl, pH 7.5 
Table 2.1. Media and solutions for mammalian cell culture. 
 
2.1.5.  Oligoribonucleotides 
  
The following tables outline the primers and oligonucleotides used in 
this thesis. For quantitative PCR analysis primers were used as 
previously described (Plumet and Gerlier, 2005). 
  
Genomic region Primer Sequence Sequence (5’  3’) 
forward ACCAAACAAAGTTGAGTAAG 
Le-N 
reverse GATGTAATGGGTGGTGGTTTGTC 
forward AGTGAGAATGAGCTACCG 
N 
reverse TGTCTAGGGGTGTGCC 
forward GAACTCAATCCCGACCTGAA 
P 
reverse GCTGTCCTCTGGAACTGGTC 
forward AACGCAAACCAAGTGT 
M 
reverse TGAAGGCCACTGCATT 
forward TGCACTTCACCAGTCC 
F 
reverse AGCTTCTGGCCGATTA 
forward ACATACCTACCTGCGG 
H 
reverse AGTAAGAAAATGAGCGGC 
forward GTGTGAAAGCGACGAG 
L 
reverse TGTTCCACGAAGATCCT 
forward GAGAAACAGATTATTATGACGGG 
L-tr 
reverse TGTTCCACGAAGATCCT 
Table 2.2. Primers used for quantitative PCR. 
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For synthesis of in vitro transcripts following primers were used 
(Table 2.3.). The in vitro transcripts were generated by Konstantin 
Sparrer (Prof. Dr. Karl-Klaus Conzelmann). 
 
In vitro transcript Primer Sequence (5’  3’) 
forward 
GCGTAATACGACTCACTATAGGG 
ACCAAACAAAGTTGGGTAA 1 
reverse GATTCCTCTGATGGCTCCAC 
forward 
GCGTAATACGACTCACTATAGGG 
CAAACACATTATTATAGTACC 2 
reverse TAACGTCAGGGTCATCGGTG A 
forward 
GCGTAATACGACTCACTATAGGG 
CTTAGGAACCAGGTCCACAC 3 
reverse CTCCTGTCCTGGGTTGTCTGA 
forward 
GCGTAATACGACTCACTATAGGG 
CAGGTGCACCTGCGGGGAAT 4 
reverse CTTCTGATTATCCTCGTGTAT 
forward 
GCGTAATACGACTCACTATAGGG 
AACAGCCCTGACACAAGGCC 5 
reverse CTTGTGCGGT TCGGTTGTGG A 
forward 
GCGTAATACGACTCACTATAGGG 
TGTCCATCATGGGTCTCAAGG 6 
reverse GAGAGTTATATTGGGCATTAA 
forward 
GCGTAATACGACTCACTATAGGG 
GAACCTAGCCTTAGGTGTAAT 7 
reverse CCAAAACATATTGGAGATCTT 
forward 
GCGTAATACGACTCACTATAGGG 
GAGACACACACCTGTATTCTT 8 
reverse CTAGAAGCTCTGTATACCTAG 
forward 
GCGTAATACGACTCACTATAGGG 
GAAGAGTCAGATACATGTGG 9 
reverse AGAAAACCCGTTTTGGTCAAG 
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In vitro transcript Primer Sequence (5’  3’) 
forward 
GCGTAATACGACTCACTATAGGG 
GATGAAGGTACTTATCATGAG 10 
reverse TGACCTTTCATCAGAGTCTCA 
forward 
GCGTAATACGACTCACTATAGGG 
GCCAAGTGATTGCTGAAAATC 11 
reverse GGTACTTGTGTGGACTGGGCT 
forward 
GCGTAATACGACTCACTATAGGG 
ACAATTGTTTCATCACATTTTT 12 
reverse TATGCAAGGTAACGGTCATAA 
forward 
GCGTAATACGACTCACTATAGGG 
AGAAATGTCCTCATTGACAAA 13 
reverse CATCCGTAGTTGACTGATCCA 
forward 
GCGTAATACGACTCACTATAGGG 
GAATCGGGTTGAACTCATCTG 14 
reverse CCTTTGACCAGATCTAGAATT 
forward 
GCGTAATACGACTCACTATAGGG 
AGTAGGTAATATTGTCAAAGT 15 
reverse GCAGAGCCATCGATAAGATGG 
forward 
GCGTAATACGACTCACTATAGGG 
ATTTGGTTATGACAGATCTCA 16 
reverse TGTAAGTTTTTTCAGAGTAGG 
forward 
GCGTAATACGACTCACTATAGGG 
TTTGAAACGTGAGTGGGTTTTT 17 
reverse ACCAGACAAAGCTGGGAATAG 
Table 2.3. Primers used for PCR of in vitro transcripts.  
 
Based on the primers listed in table 2.3, the following in vitro 
transcripts were generated by PCR and T7 in vitro transcription. 
 
In vitro transcript #1 (le-N, 1-200) 
ACCAAACAAAGTTGGGTAAGGATAGTTCAATCAATGATCATCTTCTAGTGCACTTAGGATTCAAG
ATCCTATTATCAGGGACAAGAGCAGGATTAGGGATATCCGAGATGGCCACACTTTTAAGGAGCTT
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AGCATTGTTCAAAAGAAACAAGGACAAACCACCCATTACATCAGGATCCGGTGGAGCCATCAGAG
GAATC	  
	  
In vitro transcript #2 (N, 200-400) 
CAAACACATTATTATAGTACCAATCCCTGGAGATTCCTCAATTACCACTCGATCCAGACTTCTGGA
CCGGTTGGTGAGGTTAATTGGAAACCCGGATGTGAGCGGGCCCAAACTAACAGGGGCACTAATAG
GTATATTATCCTTATTTGTGGAGTCTCCAGGTCAATTGATTCAGAGGATCACCGATGACCCTGACG
TTA	  
 
In vitro transcript #3 (P, 1745-1945) 
CTTAGGAACCAGGTCCACACAGCCGCCAGCCCATCAACCATCCACTCCCACGATTGGAGCCAATGG
CAGAAGAGCAGGCACGCCATGTCAAAAACGGACTGGAATGCATCCGGGCTCTCAAGGCCGAGCCCA
TCGGCTCACTGGCCATCGAGGAAGCTATGGCAGCATGGTCAGAAATATCAGACAACCCAGGACAGG
AG	  
	  
In vitro transcript #4 (P, 2600-2800) 
CAGGTGCACCTGCGGGGAATGTCCCCGAGTGTGTGAGCAATGCCGCACTGATACAGGAGTGGACAC
CCGAATCTGGTACCACAATCTCCCCGAGATCCCAGAATAATGAAGAAGGGGGAGACTATTATGAT
GATGAGCTGTTCTCTGATGTCCAAGATATTAAAACAGCCTTGGCCAAAATACACGAGGATAATCA
GAAG	  
	  
In vitro transcript #5 (M, 4600-4800) 
AACAGCCCTGACACAAGGCCACCACCAGCCACCCCAATCTGCATCCTCCTCGTGGGACCCCCGAGGA
CCAACCCCCAAGGCTGCCCCCGATCCAAACCACCAACCGCATCCCCACCACCCCCGGGAAAGAAACC
CCCAGCAATTGGAAGGCCCCTCCCCCTCTTCCTCAACACAAGAACTCCACAACCGAACCGCACAAG	  
	  
In vitro transcript #6 (F, 5450-5650) 
TGTCCATCATGGGTCTCAAGGTGAACGTCTCTGCCATATTCATGGCAGTACTGTTAACTCTCCAAA
CACCCACCGGTCAAATCCATTGGGGCAATCTCTCTAAGATAGGGGTGGTAGGAATAGGAAGTGCA
AGCTACAAAGTTATGACTCGTTCCAGCCATCAATCATTAGTCATAAAATTAATGCCCAATATAACT
CTC	  
	  
In vitro transcript #7 (H, 8650-8850) 
GAACCTAGCCTTAGGTGTAATCAACACATTGGAGTGGATACCGAGATTCAAGGTTAGTCCCTACCT
CTTCACTGTCCCAATTAAGGAAGCAGGCGAAGACTGCCATGCCCCAACATACCTACCTGCGGAGGT
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GGATGGTGATGTCAAACTCAGTTCCAATCTGGTGATTCTACCTGGTCAAGATCTCCAATATGTTTT
GG 
 
In vitro transcript #8 (L, 9800-10000) 
GAGACACACACCTGTATTCTTCACTGGTAGTTCAGTTGAGTTGCTAATCTCTCGTGACCTTGTTGC
TATAATCAGTAAAGAGTCTCAACATGTATATTACCTGACATTTGAACTGGTTTTGATGTATTGTG
ATGTCATAGAGGGGAGGTTAATGACAGAGACCGCTATGACTATTGATGCTAGGTATACAGAGCTT
CTAG	  
 
In vitro transcript #9 (L, 10000-10200) 
GAAGAGTCAGATACATGTGGAAACTGATAGATGGTTTCTTCCCTGCACTCGGGAATCCAACTTATC
AAATTGTAGCCATGCTGGAGCCTCTTTCACTTGCTTACCTGCAGCTGAGGGATATAACAGTAGAAC
TCAGAGGTGCTTTCCTTAACCACTGCTTTACTGAAATACATGATGTTCTTGACCAAAACGGGTTTT
CT	  
	  
In vitro transcript #10 (L, 10200-10400) 
GATGAAGGTACTTATCATGAGTTAACTGAAGCTCTAGATTACATTTTCATAACTGATGACATACA
TCTGACAGGGGAGATTTTCTCATTTTTCAGAAGTTTCGGCCACCCCAGACTTGAAGCAGTAACGGC
TGCTGAAAATGTTAGGAAATACATGAATCAGCCTAAAGTCATTGTGTATGAGACTCTGATGAAAG
GTCA	  
 
In vitro transcript #11 (L, 10900-11100) 
GCCAAGTGATTGCTGAAAATCTAATCTCAAACGGGATTGGCAAATATTTTAAGGACAATGGGATG
GCCAAGGATGAGCACGATTTGACTAAGGCACTCCACACTCTAGCTGTCTCAGGAGTCCCCAAAGAT
CTCAAAGAAAGTCACAGGGGGGGGCCAGTCTTAAAAACCTACTCCCGAAGCCCAGTCCACACAAGT
ACC	  
	  
In vitro transcript #12 (L, 11700-11900) 
ACAATTGTTTCATCACATTTTTTTGTCTATTCAAAAGGAATATATTATGATGGGCTACTTGTGTCC
CAATCACTCAAGAGCATCGCAAGATGTGTATTCTGGTCAGAGACTATAGTTGATGAAACAAGGGC
AGCATGCAGTAATATTGCTACAACAATGGCTAAAAGCATCGAGAGAGGTTATGACCGTTACCTTG
CATA	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In vitro transcript #13 (L, 12600-12800) 
AGAAATGTCCTCATTGACAAAGAGTCATGTTCAGTGCAGCTGGCGAGAGCTCTAAGAAGCCATAT
GTGGGCGAGGCTAGCTCGAGGACGGCCTATTTACGGCCTTGAGGTCCCTGATGTACTAGAATCTAT
GCGAGGCCACCTTATTCGGCGTCATGAGACATGTGTCATCTGCGAGTGTGGATCAGTCAACTACGG
ATG	  
 
In vitro transcript #14 (L, 14500-14700) 
GAATCGGGTTGAACTCATCTGCTTGCTACAAAGCTGTTGAGATATCAACATTAATTAGGAGATGC
CTTGAGCCAGGGGAGGACGGCTTGTTCTTGGGTGAGGGATCGGGTTCTATGTTGATCACTTATAA
GGAGATACTTAAACTAAACAAGTGCTTCTATAATAGTGGGGTTTCCGCCAATTCTAGATCTGGTC
AAAGG	  
 
In vitro transcript #15 (L, 14750-14950) 
AGTAGGTAATATTGTCAAAGTGCTCTTTAACGGGAGGCCCGAAGTCACGTGGGTAGGCAGTGTAG
ATTGCTTCAATTTCATAGTTAGTAATATCCCTACCTCTAGTGTGGGGTTTATCCATTCAGATATAG
AGACCTTGCCTGACAAAGATACTATAGAGAAGCTAGAGGAATTGGCAGCCATCTTATCGATGGCT
CTGC	  
	  
In vitro transcript #16 (L, 15100-15300)	  
ATTTGGTTATGACAGATCTCAAGGCTAACCGGCTAATGAATCCTGAAAAGATTAAGCAGCAGATA
ATTGAATCATCTGTGAGGACTTCACCTGGACTTATAGGTCACATCCTATCCATTAAGCAACTAAGC
TGCATACAAGCAATTGTGGGAGACGCAGTTAGTAGAGGTGATATCAATCCTACTCTGAAAAAACT
TACA	  
	  
In vitro transcript #17 (L-tr, 15695-15894) 
TTTGAAACGTGAGTGGGTTTTTAAGGTAACAGTCAAGGAGACCAAAGAATGGTATAAGTTAGTCG
GATACAGTGCCCTGATTAAGGACTAATTGGTTGAACTCCGGAACCCTAATCCTGCCCTAGGTGGTT
AGGCATTATTTGCAATATATTAAAGAAAACTTTGAAAATACGAAGTTTCTATTCCCAGCTTTGTC
TGGT 
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2.2.  Microbiological methods 
 
2.2.1. Polyacrylamide gel electrophresis  
 
a) Denaturing polyacrylamide gel electrophresis for protein analysis 
For separation of proteins by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE), a 15% separation and a 5% stacking 
gel was used. For denaturation, protein samples were diluted with 
SDS loading dye and heated up to 95 ºC for 5 min. The samples were 
separated on the gel by electrophoresis with SDS-PAGE running 
buffer. After separation the gel was either stained by Coomassie or 
separated proteins were transferred to a membrane by Western blot. 
 
Buffer Composition 
4x Separation buffer 3 M Tris, pH 8.5, 0.4% SDS 
4x Stacking buffer 0.5 M Tris, pH 6.8; 0.4% SDS 
15% separation gel 
2.5 mL H2O; 2.5 mL separation buffer; 5 mL 
acrylamide; 50 µL 10% APS; 5 µL TEMED 
5% stacking gel 
2.5 mL H2O; 1 ml stacking buffer; 500 µL 
acrylamide; 40 µL 10% APS; 4.0 µL TEMED 
SDS loading dye 
110 mM Tris, pH 6.8, 15% glycerin, 4% SDS, 
5% β-mercaptoethanol 
Table 2.4. Buffers and solutions used for SDS-PAGE. 
 
 b) Native polyacrylamide gel electrophoresis for RNA analysis 
For separation of RNA a 15% polyacrylamide gel was used. The gel 
was pre-run at 200 V for 30 min in Tris-glycine buffer and afterwards 
RNA samples were separated by electrophoresis (200 V, 2h). 
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Buffer Composition 
Tris-glycine buffer (5x) 125 mM Tris; 1 M glycine 
RNA loading dye (4x) 
40% glycerol in Tris-glycine buffer;  
0.025% bromophenol blue 
Native polyacrylamide gel (15%) 
3.75 mL acrylamide; 2 mL Tris-glycine buffer 
(1x); 4.25 mL H2O; 37.5 µL 10% APS; 7.5 µL 
TEMED 
Table 2.5. Buffers and solutions used for native PAGE. 
 
2.2.2. Western blot assay 
 
Proteins were transferred from the gel to a nitrocellulose membrane 
using a semi-dry blotting system (Bio-Rad) and Western blot transfer 
buffer. The blotting was performed for 1 h with 2 mA/cm2 according to 
the membrane size. The membrane was incubated with TBS-T 
containing 5% milk powder (Roth) for 30 min at room temperature 
(RT), washed 3 times with TBS-T, and incubated overnight at 4ºC in 
TBS-T, containing 5% milk powder and the primary antibody (1 to 5 
µg/mL). The membrane was again washed 3 times with TBS-T and 
subsequently incubated with 1 µg/mL of secondary antibody in TBS-T 
for 1 h at 4 ºC. The membrane was washed 3 times, incubated and 
developed with the ECL detection kit (Thermo Scientific) according to 
manufacturer’s instructions. The signal was visualized using a 
chemiluminescence film (Amersham Bioscience). 
 
Buffer Composition 
TBS-T 
10 mM Tris, pH 8.0; 150 mM NaCl;  
0.01% Tween 20 
Wetsern blot transfer buffer 
25 mM Tris, pH 8.5; 192 mM glycione;  
0.05% SDS; 20% methanol 
Table 2.6. Buffers and solutions used for Western blot. 
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2.2.3. Immunoprecipitation 
 
Protein G Dynabeads (Invitrogen) were resuspended and washed 2 
times with citrate-phosphate buffer (CPB). Washed beads were 
resuspended in 2 bead volumes CPB containing 1 µg/mL of the 
appropriate antibody. The beads were incubated for 1 h at 4 ºC to allow 
binding of the antibody. After incubation the beads were washed 2 
times with CPB and resuspended in 2 bead volumes. Finally the beads 
were incubated with cell lysate for 1 to 4 h at 4 ºC constantly shaking. 
Afterwards, beads were washed 3 times with low-salt washing buffer. 
Depending on the following analysis, the beads were resuspended in 
SDS loading dye for SDS PAGE analysis, or protein-associated RNA 
was extracted. 
 
Buffer Composition 
Citrate-phosphate buffer 
50 mM Sodium hydrogenphosphate dibasic; 
25 mM citric acid 
Low salt washing buffer 
50 mM HEPES; 300 mM KCl; 0.05% % NP-
40; 0.5 mM DTT; protease inhibitor 
Table 2.7. Buffers and Solutions used for immunoprecipitation. 
 
2.2.4. RNA purification  
 
 a) RNA extraction 
To isolate RNA from RNP complexes, the beads were resuspended in 
proteinase K reaction buffer containing 10 U/µL proteinase K 
(Fermentas). The reaction was incubated for 30 min at 55 ºC and 800 
rpm. To extract RNA, the solution was mixed with 1 volume of acidic 
phenol (pH 4.2; Sigma) and centrifuged for 1 min at 20.000 x g. The 
aqueous phase was transferred into a new tube and mixed with 1 
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volume of a chloroform/isoamylalcohol solution (24:1 (v/v); Sigma). 
After centrifugation the aqueous phase was again transferred into a 
new tube and RNA was ethanol-precipitated as described below.  
 
Buffer Composition 
Proteinase K reaction buffer (2x) 
100 mM Tris, pH 7.5; 150 mM NaCl;  
12.5 mM EDTA; 2% SDS 
Table 2.8. Buffers and solutions used for RNA extraction 
 
b) RNA precipitation 
The aqueous phase containing the RNA was mixed with 4 volumes of 
100% ethanol.  The solution was mixed with lithium chloride (100 mM 
final concentration), sodium actetate (220 mM final concentration) and 
2 µL glycogen (Ambion). RNA was precipitated overnight at -20 ºC and 
pelleted by centrifugation. The RNA was washed with 80% ethanol and 
resuspended in the desired volume of RNase-free water. 
 
2.2.5. RNA analysis 
 
a) 5’ radiolabeling of RNA with T4 PNK 
RNA was radiolabeled in the presence of 2 µCi/µL [γ-P32] ATP 
(Hartmann Analytic) with 0.4 U/µL T4 polynucleotide kinase (PNK)  
(Fermentas). The reaction was incubated for 15 min at 37 ºC. For 
saturation the reaction was mixed with 100 µM non-radioactive ATP 
and incubation was continued for additional 5 min. The reaction was 
terminated by addition of an equal volume of stop mix and incubation 
at 95 ºC for 2 min. The samples were separated on a 15% denaturing 
acrylamide gel. The gel was exposed to a phosphorimaging screen for 1 
h and radioactivity was quantified by a STORM 860 imaging system 
(Molecular Dynamics). 
2. MATERIAL & METHODS 
	  
 
 
37	  
 
Buffer Composition 
PNK buffer  
50 mM Tris, pH 7.5; 50 mM NaCl;  
10 mM MgCl2;  5mM DTT 
Stop mix 
15 mg bromophenol blue/xylene cyanol 
150 µL 0.5 M EDTA, 600 µL H2O, 14.25 mL 
deionized formamide, pH 8.0 
Table 2.9. Buffers and solutions used for RNA 5’ radiolabeling. 
  
 b) Luciferase transfection assay 
Immunoactivity experiments were carried out in 24-well plates. 2.5 x 
105 HEK 293T ISRE FF/RFP cells were transfected with up to 250 ng 
of recovered RNA or 500 ng in vitro transcript using Lipofectamine 
2000 (Invitrogen) according to manufacturer’s protocol. After 24 h 
incubation, cells were subjected to immunoactivity experiments using 
the Dual-Glo luciferase assay system (Promega) according to 
manufacturer’s instructions. The luciferase activity was validated in a 
96-well plate reader. 
 
c) Separation of 4SU-labeled RNA from unlabeled RNA species 
RNA (~1 µg) from 4SU-treated cells was diluted in biotinylation buffer 
containing 0.2 µg/µL biotin-HDPD (Thermo Scientific). The reaction 
mix was incubated for 2 h at RT and 800 rpm in a thermomixer. The 
RNA was purified as described in section 2.2.4. For separation of 
labeled and unlabeled RNA, the samples were incubated for 10 min at 
65 ºC and subsequently cooled down to 4º C on ice. The RNA (~100 µg) 
was loaded to 100 µL of µMacs streptavidin beads (Miltenyi Biotec) 
and the reaction was incubated with slight shaking for 15 min at RT. 
The mixture was applied to µMacs columns (Miltenyi Biotec) and 
beads were separated from the supernatant by a magnetic separator. 
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The flow-through containing unlabeled RNA was collected in 600 µL 
isopropanol and centrifuged at 20.000 x g for 10 min at 4 ºC. The 
supernatant was removed and RNA was precipitated as described 
above. The RNA pellet was diluted in the desired volume of RNase-free 
water. The µMacs streptavidin beads were washed one time with 65 ºC 
washing buffer. The 1st wash, still containing unlabeled RNA, was 
treated as the flow-through. The bound RNA was washed 5 times with 
cold washing buffer and eluted with 100 µL elution buffer. The elution 
step was repeated one time. The labeled RNA was purified according to 
the RNeasy MinElute Cleanup protocol (Qiagen). 
 
Buffer Composition 
Biotinylation buffer (10x) 100 mM Tris, pH 7.5; 10 mM EDTA 
Washing buffer  
100 mM Tris, pH 7.5; 10mM EDTA; 1M 
NaCl; 0.1% Tween 20 
Elution buffer  100 mM DTT in RNase-free H2O 
Table 2.10. Buffers and solutions used for RNA labeling. 
 
2.2.6. Fluorescence microscopy 
 
Approximately 5 × 104 A549 or 293T ISRE FF/RFP cells were grown on 
glass slides in 24-well microtiter plates. Cells were infected with virus 
as indicated and 24 hours post infection (hpi), infection was visualized 
using a Zeiss LSM510 microscopy system. The	   images	  were	  edited	  with	  
Zeiss	  LSM	  5	  Image	  Examiner.	  
 
2.2.7. T7 RNA transcription  
 
Templates were generated for in vitro transcription in a PCR reaction 
adding the T7 promoter sequence (TAATACGACTCACTATA GGG) to 
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the 5’ end of the desired MeV genome fragment. The used 
oligonucleotides in the reaction are outlined in table 2.3. The PCR 
products were subsequently purified on agarose gels. RNA was 
transcribed from these templates using the Ambion MEGAshortscript 
T7 Kit according to the manufacturer’s protocols. The reaction was 
incubated over night at 37°C, followed by RNA precipitation using LiCl 
at -20°C for at least 30 minutes. The purified RNA was then subjected 
to triphosphate digestion and purified on denaturating polyacrylamide 
gels at 25 mA constant current. Gel slices containing RNA were 
incubated overnight with 450 µL probe elution buffer. Eluted RNA was 
isolated by Phenol/Chloroform/Isoamylalkohol extraction and 
precipitated with Ethanol (see section 2.2.4). 
 
Buffer Composition 
Probe elution buffer 0.5 M NH4; 1 mM EDTA; 0.2% SDS 
 Table 2.11. Buffers and solutions used for T7 RNA transcription. 
 
2.2.8. ATPase hydrolysis assays  
 
ATPase hydrolysis activity was determined using [γ-P32] ATP. Mouse 
MDA5 was purified as described previously (Motz et al., 2013) and 2 
mM of protein was preincubated with 80 pM in vitro transcribed RNA 
for 10 min at RT. The reaction was initiated by addition of ATPase 
hydrolysis buffer containing 2 mM ATP and 0.2 µCi [γ-P32] ATP. The 
hydrolysis rate was monitored over 1h and analyzed by thin layer 
chromatography (TLC). The membrane was exposed to a 
phosphorimaging screen for 1 h and quantified as described in section 
2.2.5. 
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Buffer Composition 
ATPase hydrolysis buffer 
20 mM HEPES, pH 7.5; 150 mM NaCl;  
1.5 mM MgCl2, and 2 mM DTT 
Table 2.12. Buffers and solutions used for ATP hydrolysis assays. 
 
2.2.9. SYBR green quantitative PCR analysis  
 
Quantitative PCR analysis was performed with primer pairs 
previously described (Plumet and Gerlier, 2004) using a LightCycler 
carousel based system (Roche). Total RNA from immunoprecipitations 
was subjected to DNase I treatment in order to remove DNA 
contaminations. To allow transcription of total RNA including mRNA 
species and small RNAs, a random hexanucleotide mix (Roche) was 
used for cDNA synthesis. The reaction was incubated with reverse 
transcriptase (Roche) according to manufacturer’s protocol. PCR 
products were quantified by utilization of SYBR green in relation to a 
PCR standard of known concentration. The relative abundance of RNA 
was calculated with reference to the GFP control sample. 
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2.3. PAR-CLIP approach 
 
2.3.1. Crosslinking and Immunoprecipitation of RLR-associated RNA 
from virus-infected cells  
 
A549 human lung carcinoma cells were infected with virus with an 
MOI (multiplicity of infection) of 1.0 in the presence of 400 µM 4SU. 
Infection was allowed to occur for 24 h and living cells were washed 
with PBS and exposed to 1 J/cm2 365 nm UV light using a 
photocrosslinker (Vilbert Lourmat). Cells were harvested and 
incubated in Nonidet P-40 lysis buffer for 10 min on ice. The lysate was 
cleared by centrifugation and endogenous proteins were 
immunoprecipitated for 4 h with the respective antibodies (1 µg/mL) 
bound to protein G Dynabeads. The beads were washed five times with 
high-salt wash buffer and incubated with Proteinase K for 30 min at 
55 ºC. The RNA was isolated as described in section 2.2.4. 
 
 
 
 
	  
	  
	  
Table 2.13. Buffers and solutions used for the PAR-CLIP approach. 
	  
2.3.2. cDNA library preparation and deep sequencing analysis 
 
Total RNA isolated from immunoprecipitates was prepared for 
Illumina sequencing using the mRNA-Seq library preparation kit 
Buffer Composition 
NP-40 lysis buffer  
50 mM HEPES, pH 7.5; 150 mM KCl;  
1mM NaF; 10 µM ZnCl2; 0.5% NP-40;  
0.5 mM DTT; protease inhibitor 
High-salt wash buffer 
50 mM HEPES, pH 7.5; 500 mM KCl;   
0.05% NP-40; 0.5 mM DTT; protease 
inhibitor 
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(Epicentre) according to manufacturer’s protocol. To remove ribosomal 
RNA species from the sequencing libraries a Ribo-Zero rRNA removal 
kit (Epicentre) was used. Quality of RNA-Seq libraries was validated 
on an Agilent bioanalyzer DNA chip. Sequencing was performed on the 
Illumina Genome Analyzer in the Gene Center sequencing facility 
(LAFUGA). Obtained sequences were processed with the FASTX 
toolkit in order to remove adapter sequences and reads with PHRED 
scores below 30. Remaining sequences were mapped to human and 
viral genomes by utilization of the Bowtie algorithm, allowing maximal 
one mismatch per unique read. The Bowtie sequence alignments were 
converted with SAMtools to pileup format, which was subsequently 
used for further data analysis. The relative sequence abundance was 
analyzed between RLR pull down samples and the GFP control. The 
results were visualized in R. 
 
2.3.4. Generation of Copy number variation data 
 
Copy number variations were calculated by determining the relative 
sequence abundance at each position on the genomic segment and 
calculating the average of the RLR/GFP ratios over a dynamic window 
of 200 reads. Relative sequence abundances with Log2 ratios above +1 
were defined as significantly enriched in the RLR library.  
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2.4. Bioinformatical analysis of NGS data 
  
The bioinformatical analysis was done by Katharina Hembach (Prof. 
Dr. Johannes Soeding, LMU). All bioinformatical scripts, designed for 
the analyses, were published in the Bachelor thesis “Development of 
an analysis pipeline for high-throughput genome-wide PAR-CLIP 
measurements of virus-infected cells” (Hembach, 2012). 
 
2.4.1. Transition analysis 
  
The pileup format generated from NGS data by SAMtools were filtered 
to find prominent transitions from T to C. As reference the antigenome 
of the MeVvac2 genome was used. All possible transitions were 
extracted with the script parsePileup.py written by Katharina 
Hembach and T to C transitions were isolated using filterSNP.R. 
(Hembach, 2012). 
 
2.4.2. Base content analysis 
 
The MeVvac2 genome was analyzed to find a possible correlation 
between the base content and the read coverage of RLR libraries in a 
shifting window of 10 nucleotides. Based on the method windowComp 
written by Katharina Hembach the A, T, G, C, AT, and GC content of  
(+) and (-) RNA strands were determined in a shifting window of 1 
nucleotide (Hembach, 2012). Windows started at the 5’ end of the 
MeVvac2 genome and shifted one base to the 3’ end after the base 
content was determined. This was repeated until the 3’ end was 
reached. The analysis was performed for both RLR data sets. The 
obtained results were visualized as boxplots (Chambers et al., 1983). 
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2.4.3 5-mer analysis 
 
5-mer analysis was performed on the MeVvac2 genome. All possible 
1024 5-mers were generated and the appearance of the possible 5-mers 
on the MeVvac2 genome was validated. Each 5-mer, which appears in 
the MeV genomic sequence, was set into correlation with the median 
read coverage of the (+) and (-) RNA strands. This analysis was done 
for both RLR data sets. Finally, the median of the read coverage for 
each 5-mer was computed. For the analysis, the method kmerAnalysis 
was written by Katharina Hembach (Hembach, 2012). The parameters 
used in this approach were k = 5 to search for 5-mers and the median 
coverage threshold T = 0 to report all 5-mer appearances independent 
from the read coverage. 
To identify, 5-mers with a significant median read coverage, the 
coverage expected by chance was calculated as a reference. Therefore, 
the MeVvac2 genome was divided into fragments of 20 nucleotides in 
length. The fragments were then rearranged in a randomized manner. 
This shuffled genome was used to repeat the shuffling and 5-mer 
analysis 100 times. After each search the method repeatedAnalysis, 
written by Katharina Hembach, computed the medians of the read 
coverage of each 5-mer and sorted them in descending order (Hembach, 
2012). 
Finally, 5-mers from the original genome were sorted according to 
their medians and compared to the medians of the shuffled genome.  
   
2.4.4. In silico RNA secondary structure prediction 
 
RNA secondary structure prediction from MeV genome or in vitro 
transcripts was performed by utilization of RNAfold from the 
ViennaRNA package, using standard parameter settings. Therefore, 
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the genome was divided into 201 nucleotide fragments with a shifting 
window of 5 nucleotides. The sequences were folded in silico and each 
predicted secondary structure, represented in dot-bracket notation, 
was then analyzed for specific structural features (Hembach, 2012). 
The linear relationship of structural parameters between different 
data sets was determined with the Pearson correlation coefficient and 
set into correlation with the mean read coverage of NGS libraries. 
 
2.4.5. In silico prediction of RNase L cleavage sites 
 
Based on the literature the 8 most prominent RNase L cleavage sites 
were investigated in this thesis (Han et al., 2004). For this, the 
MeVvac2 genome was divided into fragments of 500 nucleotides. These 
fragments were then in silico folded using RNAfold. Based on the dot-
bracket notation of the predicted structures, RNase L cleavage sites in 
single-stranded regions were determined. The occurrence of each 
analyzed cleavage site in the 500 nucleotides window was then set into 
correlation with the read coverage of RLR libraries. The results were 
visualized with R. 
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3. Results 
 
3.1. Establishing the PAR-CLIP method 
 
3.1.1. Validation of 4SU incorporation efficiency into measles virus 
RNA 
  
To establish the PAR-CLIP (Photoactivatable-Ribonucleoside-
Enhanced Crosslinking and Immunoprecipitation) technique (Figure 
1.6.) in the lab and to test its suitability for the identification of 
naturally occurring RNA ligands of RLR proteins, the incorporation 
level of photoactivatable 4SU into viral RNA was validated. A549 
human lung carcinoma cells were infected with MeV at a MOI 
(multiplicity of infection) of 1.0 in the presence of 400 µM 4SU. 
Infection was allowed to occur for 24 hours. Cells were harvested and 
total RNA was isolated. The RNA was incubated with biotin to 
separate 4SU-labeled RNA by streptavidin purification (see section 
2.2.5.). The fractions of 4SU-labeled and unlabeled RNA were analyzed 
by quantitative (q)PCR analysis (Figure 3.1.). 
The data indicate that photoactivatable nucleosides are incorporated 
into viral RNA. The relative incorporation levels of 4SU into the N 
gene and into the 5’ end of the MeV genome, representing the L gene-
trailer region, is roughly 50%. However, according to the control, large 
amounts of 4SU are still incorporated into endogenous RNA, as it is 
shown for the relative RNA ratios of GAPDH (Figure 3.1.). Thus, the 
data suggest that 4SU is indeed incorporated into viral RNA, which is 
the first requirement for studying viral RNA ligands utilizing the PAR-
CLIP approach. However, significant amounts of 4SU also incorporate 
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into endogenous RNA, suggesting a competition between viral and 
endogenous RNA for the photoactivatable nucleoside analog.         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.2. Comparison of RNA recovery between PAR-CLIP and a 
common pull down approach  
 
 For further validation, PAR-CLIP was compared with a common pull 
down technique previously used for the identification of SeV DI 
particles as potent RIG-I inducers (Baum et al., 2010). A549 cells were 
!"
#$
!"
%
#$
!"
%
!"
#$
!"
%
#$
!"
%
!"
#$
!"
%
#$
!"
%
&$'( )*+, )+,*
)*-./
01023
01024
0102-
01025
2
!
2
01025
01024
0102-
#$
!"
%
!"
#$
!"
%
#$
!"
%
!"
#$
!"
%
#$
!"
%
!"
#$
!"
%
&$'( )*+, )+,*
)*-./
"#$%
01024
0102-
01025
2
#$
!"
%
!"
#$
!"
%
#$
!"
%
!"
#$
!"
%
#$
!"
%
!"
#$
!"
%
&$'( )*+, )+,*
)*-./
&'()*
67
89*
:
;
<*
6=
>?$
@
67
89*
:
;
<*
6=
>?$
@
67
89*
:
;
<*
6=
>?$
@
Figure 3.1. Incorporation efficiency of 4SU into viral RNA. 4SU incorporation efficiency was 
analyzed for the N gene and a region corresponding to the L-trailer region at the genomic 5’ 
end. MeV-infected cells were treated with 4SU and 24 h later 4SU-labeled RNA was separated 
from unlabeled RNA by biotinylation and streptavidin purification. The fractions were 
analyzed by (q)PCR. As controls, incorporation levels from mock-infected samples and 4SU-
free samples were analyzed. Incorporation into endogenous RNA was validated in the case of 
GAPDH.    
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infected with SeV at high MOI in the presence of 400 µM 4SU and 
infection was allowed to occur for 24 h. Part of the cells was then 
exposed to 365 nm UV for crosslinking and endogenous RIG-I was 
immunopurified. The recovered RNA was isolated and subjected to 
(q)PCR analysis and immunoactivity experiments.  
The analysis reveals that treatment of cells with 4SU and exposure to 
365 nm UV lead to a reduction of immunostimulatory activity of RIG-I-
associated RNA to 50% (Figure 3.2. A). However, (q)PCR data show 
that the crosslinking approach yields improved RNA recovery with an 
increase of 50% in SeV DI particles in comparison to the non-
crosslinking method (Figure 3.2. C). Furthermore, fluorescence 
microscopy experiments confirm that treatment of cells with 
photoactivatable nucleoside does not affect cell viability or virus 
replication (Figure 3.3.). In conclusion, the data indicate that the 
crosslinking technique is a promising tool to study in vivo occurring 
RNA ligands for RLR proteins. 
 
3.1.3. Determination of viral concentration for infection experiments 
 
A549 cells were infected with different concentrations of a genetically 
modified MeVvac2 strain encoding GFP (provided by Prof. Dr. Karl-
Klaus Conzelmann) in order to identify the optimal viral concentration 
for the PAR-CLIP experiment. 24 hpi (hours post infection) MeV 
replication was visualized by fluorescence microscopy (Figure 3.4.). 
The fluorescence images indicate that an increasing number of cells 
become infected in a concentration-dependent manner. According to 
the results an MOI of 1.0 was chosen for further experiments. At the 
given concentration A549 cells remain viable and a reasonable amount 
of cells become infected (Figure 3.4. C). Although, higher titers would 
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lead to a better infection efficiency, these concentrations are not 
feasible due to practical problems in MeV production. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Next, MeV infection was investigated on a protein level. Therefore, 
A549 cells were infected with virus  (MOI of 1.0) in the presence or 
absence of 4SU. Viral protein expression was validated by Western blot 
analysis 6 and 24 hpi, respectively (Figure 3.4. B). The obtained data 
show slight expression of P and V protein 6 hpi indicating that the 
transcription machinery is already activated shortly after the virus 
entered the cell. 24 hpi translation of viral proteins become strongly 
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Figure 3.2. Validation of crosslinking and immunoprecipitation of RIG-I/RNA complexes from 
24 h virus-infected cells. (A) Immunostimulatory activity of RNA from RIG-I and control (GFP) 
crosslinking samples (365 nm UV) in comparison to non-crosslinking immunoprecipitates (no 
UV) were validated by transfection of RNA into 293T ISRE FF/RFP reporter cells. (B) 
Immunoblot (IB) analysis of RIG-I pull down experiments shows the efficiency of RIG-I 
immunopurification in comparison to GFP. (C) Comparison of RNA recovery levels by (q)PCR 
analysis of RIG-I-associated RNA from SeV-infected cells (n=3). Q-PCR reactions incorporated 
human actin β controls and relative abundance of each RNA was calculated with reference to 
this control.  
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upregulated as reflected by the robust expression of viral proteins in 
the cell lysate of A549 cells.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. (A) MeVvac2GFP-infected A549 cells. A549 cells were infected with MeVvac2GFP 
at different MOIs and 24 hpi, infection was monitored by fluorescence microscopy. Lower: 
Schematic representation of the genome organization of the genetically modified MeVvac2GFP 
strain. (B) Viral replication at different time points. By Western blot analysis production of 
viral P and V protein was monitored 6 hpi and 24 hpi in the presence or absence of 400 µM 
4SU, respectively. β actin was used as a loading control . 
Figure 3.3. Effect of 4SU on viral replication. A549 cells and 293T ISRE RFP cells were 
infected with SeVGFP and SeV-C, respectively. Viral replication was allowed to proceed over 
24 h and then analyzed by fluorescence microscopy. (A) Cells were grown in the absence of 
virus as a negative control. (B) Cells were infected with the respective virus at a high MOI 
and 4SU was added as indicated (at 0 hpi and/or 6 hpi). Viral replication was validated by 
viral GFP expression or by RFP production from the reporter cells. 
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Comparison between 4SU treated and untreated cells indicate that the 
nucleoside has no significant impact on viral gene expression, which is 
in good agreement to the above-mentioned results (Figure 3.4. B). 
However, it is noted that endogenous protein levels (β-actin) 
dramatically decrease 24 hpi, suggesting that at late time points of 
infection the virus already interferes with the cell cycle. 
 
3.1.4. Validation of RNA recovery efficiency from MeV-infected cells 
 
To finally show that the crosslinking strategy yields higher RNA 
recovery levels from RIG-I and MDA5 immunoprecipitates, A549 cells 
were infected with MeV in the presence of 4SU followed by 365 nm UV 
exposure 24 hpi. As a reference, control pull downs for RIG-I and 
MDA5 were performed. The recovered RNA from normalized cell 
lysates was radioactively labeled and separated by native PAGE 
electrophoresis (Figure 3.5.). The phosphorimages of separated RNAs 
clearly show an increased RNA recovery from virus-infected samples 
treated with 4SU and UV light in comparison to the non-crosslinking 
approach (Figure 3.5. A). Quantification of the RLR-associated RNA 
confirms an improved RNA recovery level up to 30% (Figure 3.5. B). 
Remarkably, RLR immunoprecipitates from non-infected cells do not 
yield improved RNA recovery even with PAR-CLIP, suggesting that 
RLRs require viral infection in order to sense RNA ligands. 
 
3.1.5. 4SU treatment and 365 nm UV exposure yield immunoactive 
RNA in an RLR-dependent manner  
 
After determining the initial parameters for the PAR-CLIP 
experiment, different viruses including negative-strand (-) RNA 
viruses (MeV and Rabies) and postive-strand (+) RNA viruses 
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(Encephalomyocarditis virus (EMCV) and, Mengo virus) were tested. 
A549 cells were infected with the respective virus in the presence of 
the photoactivatable nucleoside and 365 nm UV crosslinked 24 hpi. 
RIG-I and MDA5 were immunoprecipitated and the recovered RNA 
was subjected to immunoactivity experiments. The data reveal that 
immunoactive RNA is co-purified in a RIG-I- and MDA5-dependent 
manner from MeV-infected cells. The induction is significant in 
comparison to the negative control (Figure 3.6.). In case of RIG-I-
associated RNA an immunostimulatory effect is observed that is 2600-
Figure 3.5. RNA recovery efficiency from MeV-infected cells. (A) Upper: Phosphorimage of 
32P-labeled RNA from different pull down conditions. RLR-associated RNA from MeV-infected 
or non-infected A549 cells in the presence or absence of 4SU, were radioactively labeled and 
separated by native PAGE. Lower: Western blot analysis of normalized cell lysates. (B) 
Quantification of relative RNA recovery levels from RLR immunoprecipitates. Phosphorimages 
of RLR-associated RNAs were quantified with ImageJ. The highest value was set to 1.  
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fold higher in comparison to the control. For MDA5 a 800-fold 
induction is reported (Figure 3.6.). However, RNA co-purified from 
additional viruses does not show significant immunostimulatory 
activity. The reason for this may lie in the heterogeneity of viral 
replication cycles. Especially, replication of picornaviruses reveals 
remarkable differences in regard to Mononegavirales. But also closely 
related viruses like measles and rabies exhibit differences in their 
mode of replication that hamper the investigation of viral RNA ligands 
from different viruses with one established protocol. In respect to such 
discrepancies, the crosslinking approach has to be fine-tuned and 
adjusted for each viral background.  
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Figure 3.6. Immunoprecipitation of RLR-associated RNA from cells infected with different 
types of viruses. Validation of immunostimulatory activity of RNA from RIG-I, MDA5, and 
GFP immunoprecipitates upon transfection into 293T ISRE-FF/RFP cells (n=3). 
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3.2.  Next generation sequencing (NGS): an unbiased 
method to study RLR-associated viral RNA 
 
3.2.1. NGS reveals regions within the Measles virus genome 
recognized by RIG-I and MDA5 
 
In light of the results mentioned in section 3.1., the focus of this thesis 
was on the investigation of endogenous RLR ligands from MeV-infected 
cells. Concerning this question, A549 cells were the preferred cell 
system, since these cells adhere as a monolayer to the cell culture dish, 
allowing for homogenous 365 nm UV crosslinking. Furthermore, A549 
cells exhibit robust RLR expression, making them ideally suited for the 
analysis of naturally occurring RNA ligands of the endogenous sensor 
proteins. 
Due to the complex RNA composition in a virus-infected cell, the 
analysis of specific RNA ligands for a receptor protein is challenging 
(section 1.4.). To shed light on the exact nature of RIG-I and MDA5-
associated RNAs derived from MeV-infected cells, NGS (Next 
generation sequencing) analysis on isolated RNA species was 
performed. The application of NGS holds the advantage to investigate 
RNA without any prior knowledge about the nature of the molecule. In 
more traditional methods, like Northern blot and quantitative PCR, 
the nature of probes and primers can greatly influence the 
experimental outcome and commonly introduce bias to the data set. 
These disadvantages can be eliminated by the NGS technology. 
 Co-purified RNA from MeV crosslinking experiments was prepared for 
NGS analysis according to the Epicentre RNA-Seq protocol and 
sequenced on the Illumina Genome Analyzer (see section 2.3.2.). The 
obtained sequences were mapped to the MeV antigenome and relative 
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Figure 3.7. Next generation sequencing (NGS) of RLR-associated RNA from MeV-infected 
cells. (A) RNA from RIG-I pull down (red), (B) MDA5 pull down (blue), and (C) GFP pull down 
(black) from MeV-infected cells were subjected to Illumina NGS analysis. The obtained 
sequences were mapped to the MeV antigenome and relative abundances of these sequences 
between RIG-I, MDA5, and GFP pull down were compared. The lower panel shows an overlay 
of all three libraries (D) Western blot analysis shows the efficiency of RIG-I and MDA5 
immunopurification in comparison to the GFP pull down. (E) Validation of 
immunostimulatory activity of RLR-associated RNA. 
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abundances of these sequences between RIG-I, MDA5, and GFP pull 
downs were compared. Individual peaks on the graph correspond to a 
sequencing read that starts at that particular position. The x-axis 
corresponds to all possible 15,894 positions in the MeV antigenome and 
the y-axis shows the number of reads that begin at that position. 
(Figure 3.7.). 
 Analysis of the reads reveals that RIG-I and MDA5 bind to same 
regions within the L genomic segment. In addition, RIG-I, but not 
MDA5, binds to the 3’ and the 5’ ends of the MeV genome  (Figure 3.7. 
A, B). These regions correspond to leRNA and trRNA that are 
generated in the course of replication (Mottet et al., 1990). 
Furthermore, the data indicate that RIG-I binds to MeV-derived RNA 
with higher affinity in comparison to MDA5. This observation suggests 
a major role for RIG-I in RNA recognition from MeV-infected cells, 
which is also reflected by the increased immunostimulatory activity of 
isolated RNA from RIG-I immunoprecipitates. Accorrding to the 
immunostimulatory activity, RIG-I-associated RNA gives a 4-fold 
induction in regard to MDA5-associated RNA (Figure 3.7. D, E). 
 
3.2.2. Analysis of NGS data reveals striking differences in the strand-
specificity of RIG-I and MDA5 
 
 Based on the protocol used for cDNA library preparation, sequencing 
reads could be separated according to their strand orientation. During 
cDNA synthesis adaptors were specifically ligated to the 3’ and 5’ ends, 
thereby keeping the information of strand specificity during the 
sequencing run. Separation of sequences reveals remarkable 
differences between RIG-I and MDA5 libraries (Figure 3.8.). In regard 
to RIG-I, the sequence distribution indicate that RNA sequences of 
positive polarity, which represent either antigenome or mRNA 
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transcripts, are predominantly enriched in the genomic leader region 
and within distinct region of the L genomic segment (Figure 3.8., 
red). Sequences of negative polarity, which represent genomic RNA, 
originate from the 5’ end corresponding to the trailer region and from 
distinct regions within the L gene (Figure 3.8., magenta). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of MDA5-associated RNA reveals that sequences of positive 
polarity are enriched within the L gene originating from similar 
Figure 3.8. Analysis of NGS data revealed differences in the strand specificity of RNAs 
recognized by RIG-I and MDA5. RNA NGS libraries were generated based on the strand-
specific mRNA sample preparation protocol from Epicentre (see section 2.3.2). The Epicentre 
protocol encompasses sequential ligation of 5’ and 3’ adapters to RNA molecules, thus 
preserving strandness information. RLR-associated sequences were separated into (+) and (-) 
RNA and mapped against the MeV antigenome. Upper: RIG-I-associated sequences in 
comparison to the control (black, grey) mapped to the antiviral genome.  (+) RNA is shown in 
red; (-) RNA is shown in magenta. Lower:  Sequences representing  (+) RNA (blue) and (-) RNA 
(cyan) from MDA5 libraries were mapped in comparison to the control (black, grey). 
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regions as (+) RNA from the RIG-I library (Figure 3.8., blue). 
However, MDA5 does not bind to sequences originating from the 3’ and 
5’ ends of the MeV genome. Comparison of enriched (-) RNA from RIG-
I and MDA5 libraries shows that in contrast to RIG-I, MDA5 does not 
bind to RNA of negative polarity, which represents the viral genome 
(Figure 3.8., cyan). Moreover, the data evidently rules out the 
possibility that MDA5 recognizes heterogeneous RNA duplexes of (+) 
and (-) RNA that might represent replication intermediates as 
previously described (Feng et al., 2012). In fact, the results suggest 
that MDA5 bind (+) RNA that could either represent MeV mRNA or 
antigenomic RNA species. 
 
3.2.3. Copy number variation (CNV) analysis: a bioinformatical tool 
to validate significant sequence enrichment between NGS 
libraries 
 
 To validate the significant enrichment of RIG-I- and MDA5-associated 
RNA in comparison to the negative control, copy number variation 
(CNV) data were generated (Wood et al., 2010). This analysis allowed 
to compare enriched sequences in each library in regard to the control. 
CNVs were validated by determining the normalized sequence 
abundances at each position on the genomic segment and by 
calculating the average of the RLR/GFP ratios over a dynamic window 
of 200 reads. Sequence abundances with Log2 ratios above +1 were 
defined as significantly enriched in the RLR libraries (Figure 3.9.). 
The CNV karyograms indicate that RIG-I-associated RNA of positive 
polarity is remarkably enriched across the whole genome with the 
majority of specific sequences in the N genomic and L genomic regions 
(Figure 3.9., A and 3.10.). In the case of (-) RNA, CNV data reveal 
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slight enrichment for the 5’ end of the MeV genome but not for the 3’ 
region (Figure 3.9., A). 
 In contrast to RIG-I-associated RNA, CNV analysis for MDA5-
associated RNA clearly indicates that (+) RNA is significantly enriched 
from region corresponding to the L genomic segment, while no 
enrichment is observed for (-) RNA (Figure 3.9. B and 3.10.). The 
data nicely correlate with the NGS analysis demonstrating that 
distinct regions of the MeV genome are indeed specifically enriched in 
an RIG-I- and MDA5-dependent manner in comparison to the control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. Generation of NGS-based copy number karyograms from RLR RNA sequencing 
libraries. Data points with log2 ratios above 1 represent sequencing reads that were 
significantly enriched in comparison to the control (GFP) library (red, dashed line). (A) The 
copy number profiles for RIG-I are illustrated. (left) copy number variation data representing 
(+) RNA; (right) copy number variation data representing (-) RNA. (B) Copy number profiles 
for MDA5 libraries. (left) copy number variation data representing (+) RNA; (right) copy 
number variation data representing (-) RNA. 
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Figure 3.10. Karyograms of copy number variation analysis for MeV genomic segments. The 
calculation is based on a dynamically calculated window size. The algorithm determines the 
start and end points in an interval 200 reads which are used for the CNV calculation. CNV 
values with a log2 ratio above 1 are significantly enriched in comparison to the control library. 
(Upper) Copy number variation data for each genomic segment. Each data point corresponds to 
a CNV value for the calculated window. The mean values for RIG-I and MDA5 are shown in 
red and blue, respectively. Standard deviations are represented in grey. The high log2 ratios in 
the M and F genes, are caused by the low copy numbers in GFP in comparison to RLR libraries 
(Lower). Alignment of sequences against the MeV antigenome from RLR and GFP 
immunoprecipitates. The mean coverage of sequences are shown for RIG-I (red), MDA5 (blue), 
and GFP (black) for (+) RNA. 
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3.3. Quantitative PCR analysis: Confirmation of NGS 
experiments by an independent approach 
 
 To independently validate the relative amount of RLR-associated RNA, 
(q)PCR analysis was performed. The obtained copy read numbers were 
normalized to compare the genomic segments in the RIG-I and MDA5 
samples (Figure 3.11. A, B). Analysis of relative abundances confirms 
that RIG-I specifically enriches sequences in the 3’ and the 5’ regions of 
the viral genome, representing antigenome or viral mRNA. 
Interestingly, the analysis shows that RIG-I-associated RNA from the 
3’ end most likely represent leRNA-N mRNA read-through transcripts 
or abortive replication products, but no mRNA from the N genomic 
segment (Figure 3.11. A). In regard to MDA5, RNA is enriched in the 
case of the L genomic segment and partly from the H gene, but not 
from upstream genomic regions (Figure 3.11. A). 
The analyzed regions within the MeV genome do not exactly reflect the 
results of the NGS experiment. For each genomic segment, primer 
pairs were chosen that represent 200-nucleotide regions at the end of 
each gene, thereby covering only a very restricted area of the genome. 
Nevertheless, the obtained data are in good agreement to the results of 
the NGS analysis, indicating that RIG-I and MDA5 indeed recognize 
RNA originating from the L gene of the MeV genome. 
 Furthermore, the relative abundances in the RIG-I sample were up to 
40-fold higher in comparison to MDA5 (Figure 3.11. C). This again 
indicates that RIG-I binds to MeV RNA with a much higher affinity in 
comparison to MDA5. This conclusion is further supported by 
immunoactivity experiments, where relative immunostimulatory 
activity of RIG-I-associated RNA is 20-fold higher in comparison to 
MDA5 (Figure 3.11. D). 
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3.4. Bioinformatical analysis: Characterization of the 
RLR-associated RNAs 
  
 The quality of NGS data was assessed by bioinformatical approaches. 
Based on the obtained results, the nature of endogenous RNA ligands 
for RLRs was further characterized. The bioinformatical analysis was 
performed in collaboration with the group of Dr. Johannes Soeding. 
The main contribution to this part of the thesis came from Katharina 
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Figure 3.11. Quantitative PCR analysis of RLR-associated RNA from MeV-infected cells. 
(A) Comparison of (+) RNA levels between RIG-I and MDA5 immunoprecipitates for each 
genomic segment at 24 hpi. Relative RNA ratios were normalized against the control 
(GFP) library. (B) Western blot analysis of RLR pull down experiments show the efficiency 
of RIG-I and MDA5 immunopurification in comparison to the GFP pull down. (C) 
Immunstimulatory activity of RLR-associated RNA at 24 hpi. The qPCR reactions 
incorporated multiplexed human actin β internal controls and relative abundance of RNA 
was calculated with reference to this control.  
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Hembach, who wrote the bioinformatical scripts for the analysis of the 
NGS data and did the evaluation. Parts of the results were published 
in her Bachelor thesis “Development of an analysis pipeline for high-
throughput genome-wide PAR-CLIP measurements of virus-infected 
cells” (Hembach, 2012). 
 
3.4.1. Mutational analysis: Deciphering the exact binding site 
 
 According to the paper from Hafner et al. the most significant 
advantage of the PAR-CLIP technique to commonly used pull down 
strategies, is the introduction of specific T to C transitions at the 
crosslinking sites between 4SU-labeled RNA and the RNA-binding 
protein (Hafner et al., 2010). It is speculated that these transitions are 
caused by a chemical structure change of the 4SU nucleobase upon 
crosslinking to the amino acid side chain of the protein. This alteration 
could result in modified donor/acceptor properties of the hydrogen 
bond, directing the preferential incorporation of dG rather than dA 
during reverse transcription (Hafner et al., 2010). The resulting T to C 
transitions could be used to exactly pinpoint the binding sites of the 
respective protein in the NGS libraries.  
To identify putative binding sites by mutational analysis, the NGS 
data was filtered for all possible transitions and transversions (see 
section 2.4.1.). The analysis of (+) RNA from RIG-I immunoprecipitates 
revealed that beside T to C transitions, other mutations (e.g. C to T 
and G to T) occur at frequencies that are comparable to those of T to C 
(Figure 3.12. A). Furthermore, the relative mismatch frequencies are 
comparable between the different libraries, with the exception for G to 
T, which is the most frequent mutation in (+) RNA of the RIG-I library 
(Figure 3.12. A).  
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This transversion could result from crosstalk phenomena in the base-
calling step. The nucleobase pairs A/C and G/T exhibit similar 
emission spectra that could result in wrong base calls in the Illumina 
Figure 3.12. Analysis of transition/transversion frequencies in the NGS data set. For the 
mutational analysis, pileup files were filtered for all possible transition/transversions. Each 
barplot represents the conversion frequency of a particular nucleobase. The y-axis reflects the 
total number of reads that contain the specified mutation (x-axis). (A) Barplots for each 
possible transition in the RIG-I dataset. (B) MDA5 dataset. (C) GFP dataset. Left: (+) RNA; 
right: (-) RNA. 
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sequencing strategy (Li and Speed, 1999). However, if this were the 
case, (+) RNA from MDA5 and GFP would also show an increased 
frequency in G to T transversions. Interestingly, no significant 
mismatch numbers were found in (-) RNA of the RIG-I library despite 
the high copy numbers (Figure 3.8. and 3.12. A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In regard to MDA5 and GFP, T to C transitions are indeed the most 
frequent mutations observed in the NGS data (Figure 3.12. B, C). 
These conversions have a 2-fold higher frequency in comparison to the 
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Figure 3.13. Characterization of T to C transitions in the NGS data. The observed T to C 
transitions can be divided into two groups. (A) T to C conversion with a high frequency 
originate from 100% of the read counts in the NGS libraries. These mismatches could 
represent wrongly annotated nucleobases but are unlikely to result from specific crosslinks at 
4SU moieties. (B) The majority of T to C conversions occurs only at a few percent in the read 
counts of NGS libraries (below 5%), which indicates that these transitions originate from non-
crosslinked 4SU in the RNA molecules and therefore do not represent interaction sites 
between the RNA and the receptor protein. T to C transitions were visualized using the 
Integrative Genomic Viewer (James et al., 2011). 
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second most common transition (A to G). At this stage of the analysis it 
is not clear, whether the observed T to C transitions result from 
crosslinks between MeV RNA and the receptor proteins, or whether 
unspecific conversions from non-crosslinked 4SU-labeled RNA 
contribute to the T to C transition rate. However, the slight increase in 
T to C rather suggests that the crosslinking did not induce covalent 
linkages at 4SU moieties of the RNA. This is further supported by the 
observation that some T to C conversions can be found in almost 100% 
of the total read counts of all libraries (Figure 3.13. A). This indicates 
that the T to C mutations result from wrongly annotated nucleobases 
in the reference genome, rather than from specific crosslinks at the 
interaction sites. Even if the crosslinking strategy efficiently induced T 
to C conversions, one would expect a maximum transition rate of 80% 
in comparison to a non-crosslinking method (Hafner et al., 2010). 
Furthermore, the majority of T to C transitions occurs only at a few 
percent in the total read counts (Figure 3.13. B). According to Hafner 
et al. the average T to C conversion rate derived from background non-
crosslinked 4SU-labeled sites is near 5% (Hafner et al., 2010). This and 
the occurrence of T to C in the GFP library, indicate that these 
transitions do not result from specific crosslinking sites, but rather 
represent background conversions or mismatches introduced during 
the sequencing run. 
It is possible that the improved RNA recovery in comparison to non-
crosslinking techniques (Figure 3.5.) is based on the high doses of UV 
exposure, applied in the modified PAR-CLIP protocol. This could result 
in unspecific crosslinks between non-substituted nucleobases and the 
interacting amino acid side chains of the protein. Based on the 
mutational analysis, T to C transitions are preliminary considered to 
be not reliable to investigate RLR binding sites in the viral RNA. 
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3.4.2. Analysis of the base content in a shifting window of 10 
 
Since the transition analysis did not allow a reliable interpretation for 
preferred binding sites, the base content of the MeV genome was 
analyzed and set into correlation to the mean read coverage of 
sequences. It is possible that a simple nucleotide bias in the viral 
genome leads to a preferred binding of RNA sequences towards other 
species. To address this, the genome was analyzed in windows of 10 
nucleotides with a shifting number of 1 nucleotide. The numbers of 
bases in the analyzed windows were set into correlation with the mean 
read coverage of RIG-I and MDA5 libraries (Figure 3.14. and 3.15.). 
The results are represented as boxplots for the indicated occurrence of 
the base content (x-axis) and the corresponding mean read coverage in 
the window (y-axis). The black line in each box represents the median 
for each analyzed occurrence of the respective nucleobase. Each boxplot 
is drawn with a notch around the median. Non-overlapping notches 
between two boxes indicate that their medians differ statistically 
significant (Chambers et al., 1983). 
Based on the analysis of the calculated medians, no significant 
nucleotide bias is observed that might explain the sequence 
enrichment in RLR libraries (Figure 3.14. and 3.15.). In regard to 
RIG-I, a slight correlation between the G content of (+) RNA and the 
mean read coverage of sequences is observed. However, this is in 
contrast to the G/C composition, which does not show any correlation 
with the mean read coverage of (+) RNA sequences (Figure 3.14. A). 
Indeed, the data rather suggest that A/U-rich sequences slightly 
correlate with the mean read coverage of (+) RNA (Figure 3.14. A), 
while sequences with a high G/C content, tend to correlate with the 
mean read coverage of (-) RNA (Figure 3.14. B).  
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Figure 3.14. Analysis of the base content in a shifting window of 10. Six individual plots 
represent the base content in a shifted window of 10 nucleotides. Each plot contains boxplots of 
the indicated occurrence (x-axis) of the particular base content and the corresponding mean 
read coverage in the window (y-axis)  (A) Boxplots of the base content and the mean read 
coverage of (+) RNA from RIG-I libraries. (B) Boxplots of the base content and the mean read 
coverage of (-) RNA from RIG-I libraries.  
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Figure 3.15. Analysis of the base content in a shifting window of 10.  Six individual plots 
represent the base content in a shifted window of 10 nucleotides. Each plot contains boxplots of 
the indicated occurrence (x-axis) of the particular base content and the corresponding mean 
read coverage in the window (y-axis). (A) Boxplots of the base content and the mean read 
coverage of (+) RNA from MDA5 libraries. (B) Boxplots of the base content and the mean read 
coverage of (-) RNA from MDA5 libraries.  
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In the case of MDA5, similar results were obtained (Figure 3.15. A, B) 
indicating that enriched sequences from RIG-I and MDA5 
immunoprecipitates have the same base composition. According to the 
high similarity between the different medians and the overlapping 
notches of the particular boxes, it is obvious that the sequence 
enrichment, observed in the RLR libraries, is not caused by a simple 
nucleotide bias. 
 
3.4.3. 5-mer analysis with the objective to study viral sequence motifs 
 
Towards the analysis of possible sequence motifs in the MeV genome, 
5-mers and their correlation with the median read coverage of RLR 
libraries were investigated. For this, all 1024 possible 5-mers were 
generated and for each 5-mer, which appears in the MeV genome, the 
median read coverage was determined. In order to identify 5-mers with 
a significant median read coverage; the coverage expected by chance 
was also calculated. Therefore, the MeV genome was divided into 
fragments of 20 nucleotides and rearranged in a randomized order. 
With this shuffled genome the same 5-mer analysis was performed. 5-
mers with the 20 highest medians were sorted in descending order 
(Figure 3.16. and 3.17., Table 3.1. and 3.2.). 
Comparison of 5-mers with an appearance above 5 and a higher 
median read coverage in regard to the expected values indicate that 
these 5-mers tend to be rich in A/U rather than G/C (Table 3.1. and 
3.2.). Especially, the sequence UAGUA is slightly enriched in 
comparison to the expected medians in the (+) RNA of RIG-I and 
MDA5 libraries (Figure 3.16. A (#4) and 3.17. A (#2)). 
In addition, the sequence CAUUC from MDA5 (+) RNA shows a 
slightly higher median in comparison to the control value (Figure 
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3.17. A (#7)), which was not the case for RIG-I. In regard to (-) RNA, 
the sequence motifs GCUAC and GCUUA from the RIG-I library 
slightly correlate with a higher median read coverage (Figure 3.16. B 
(#5, #9)), while  (-) RNA from MDA5 samples does not contain any 5-
mer, which is enriched in comparison to the expected value. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Taken together, the analysis of RIG-I and MDA5 libraries indicates, 
that with the exception of a slight correlation with a few 5-mers rich in 
A/U, there is no motif, which is significantly enriched in regard to the 
expected values. The observed medians approach the expected ones 
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Figue 3.16. RIG-I 5-mer analysis. Boxplots represent the first 20 5-mers, which were sorted 
after their median read coverage in descending order. (A) 5-mers from the MeV (+) RNA 
strand are shown in black. The expected medians are in red. 5-mer number 4 (UAGUA), with 
an appearance of 9 (see Table 3.1), tend to be slightly enriched in comparison to the expected 
value. (B) In case of MeV (-) RNA, 5-mers number 5 (GCUAC) and number 9 (GCUUA) (see 
Table 3.1), which have appearances above 5 (see Table 3.1), show higher medians in 
comparison to the expected values (red). 
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exactly towards the end of the plots, evidently ruling out the possibility 
of an RNA motif-dependent recognition by the receptor proteins. 
In regard to viral evolution the lack of such a sequence motif in the 
viral genome is reasonable, since viruses are fast replicating species 
constantly changing their genome upon mutations. A conserved motif 
would have been lost over time and would no longer be available as a 
putative PAMP for RLR proteins. 
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Figue 3.17. MDA5 5-mer analysis. Boxplots represent the first 20 5-mers, which were sorted 
after their median read coverage in descending order. (A) 5-mers from the MeV (+) RNA 
strand are shown in black. The expected medians are in red. 5-mers number 2 (UAGUA) and 7 
(CAUUC), which have appearances above 5 (see Table 3.2), tend to be slightly enriched in 
comparison to the expected values. (B) In case of MeV (-) RNA, no 5-mers (black) is enriched in 
comparison to the expected values (red). 
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Table 3.1.  RIG-I 5-mer analysis. Sequences of the first 20 5-mers sorted after their medians 
in descending order. Bold sequences represent 5-mers with a higher median than the expected 
value and which appear more than 5 times in the MeV genome. 
 
 
 
 
 
RIG-I 
 (+) RNA   (-) RNA 
ranking of 5-
mer 
5-mer sequence appearance 5-mer sequence appearance 
1 GGGCG 3 CGUAU 2 
2 UUCGC 2 GACGA 2 
3 AGCGU 1 CGAAA 4 
4 UAGUA 9 CGUAC 1 
5 CGCUA 2 GCUAC 6 
6 UACGC 1 ACGCA 3 
7 CGCCU 4 UUACG 2 
8 CAUUC 6 UACGG 3 
9 UACCA 15 GCUUA 6 
10 AGUUA 12 GGCGA 3 
11 CGUGG 3 ACGAA 5 
12 GAAUA 10 GCGAG 7 
13 AUAGU 18 GAGAA 7 
14 CUAAG 11 ACUUA 10 
15 GUAGG 11 AAUUA 11 
16 AAUAG 8 CUACA 9 
17 GUACG 1 CGUGC 4 
18 GUAGA 11 GACAG 11 
19 UGGAU 15 UAAGA 13 
20 UGAAU 13 UGACG 4 
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Table 3.2.  MDA5 5-mer analysis. Sequences of the first 20 5-mers sorted after their medians 
in descending order. Bold sequences represent 5-mers with a higher median than the expected 
value and which appear more than 5 times in the MeV genome. 
 
 
 
 
 
MDA5 
 (+) RNA   (-) RNA 
ranking of 5-
mer 
5-mer sequence appearance 5-mer sequence appearance 
1 CGCUA 2 CGUAU 2 
2 UAGUA 9 GACGA 2 
3 GGGCG 3 CGAAA 4 
4 AGCGU 1 GCUAC 6 
5 CGUGG 3 CGUAC 1 
6 AGUUA 12 AGCCA 3 
7 CAUUC 6 UUACG 2 
8 UUCGC 2 ACGAA 5 
9 UUUGU 15 GCUUA 6 
10 GCGUU 5 UACGG 3 
11 GUAGG 11 CGUGC 4 
12 AAUAG 8 ACUUA 10 
13 UAACC 6 GGCGA 3 
14 UUAAC 10 CUACA 9 
15 GGAUG 22 AAUUA 11 
16 GUACC 14 UACUA 9 
17 UGUAG 9 GAGAA 7 
18 UAGCG 2 UAUGU 11 
19 UUACU 9 GUAGA 14 
20 AUAGU 18 AGCUA 7 
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3.4.4. In silico analysis of RNA secondary structures 
 
 Due to its constitution, RNA forms extensive three-dimensional 
secondary structures, which contribute to the biological function of the 
molecule. RNA secondary structures are based on intrastrand base-
pairing probabilities in the nucleotide sequence, which can give rise to 
a large variety of three-dimensional shapes (Figure 3.18.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
As indicated by the analyses in sections 3.4.2. and 3.4.3., the 
nucleotide composition in the MeV genome by its own does not explain 
the mechanism of recognition by RLR proteins. Therefore, the focus 
was turned on the secondary structure of viral RNA. It is known that 
RLR proteins bind to higher-order structures of viral RNA (Pichlmair 
et al., 2009), which activate the antiviral signaling cascade. To study a 
possible correlation between the read coverage in the NGS libraries 
and the secondary structure of viral RNA, the MeV genome was 
divided into fragments of 201 nucleotides with a shifting window of 5 
nucleotides. Each fragment was folded in silico by RNAfold (Vienna 
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Figure 3.18. Possible RNA secondary structures. 
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RNA package) using the standard parameter settings. The predicted 
secondary structures were then analyzed for specific RNA structure 
features, which were set into correlation with the mean read coverage 
of the NGS libraries (Figure 3.19. and 3.20.). 
The heatscatter plots represent the correlation of the corresponding 
structure feature with the mean coverage of the library. The color 
indicates how many data points overlap at one particular position. 
From grey to yellow there is an increase in data points. The calculated 
Pearson correlation coefficients reflect the relationship between the 
analyzed parameters and the mean coverage of RNA copy numbers. 
The data indicate that the A/U content correlates with the mean 
coverage in the RIG-I ((+) RNA = 0.273 and (-) RNA = 0.334) (Figure 
3.19.) and MDA5 ((+) RNA = 0.358 and (-) RNA = 0.348) (Figure 3.20.) 
libraries of positive and negative RNA strands. This moderate 
correlation suggests that sequences enriched by the receptor proteins 
tend to have a higher A/U content in comparison to sequences not 
recognized by RIG-I and MDA5. The result raises the possibility of a 
direct contribution of A/U-rich sequences to RLR activation. 
Furthermore, in silico analysis shows a correlation of 0.314 (0.262) in 
the case of RIG-I (MDA5) between the number of paired nucleotides 
and the mean coverage of (+) RNA (Figure 3.19. A and 3.20. A). 
Interestingly, this correlation negatively correlates with the G/C 
content of the enriched sequences (data not shown). Sequences rich in 
G/C generally form more stable RNA duplexes due to the formation of 
three hydrogen bonds. However, the data indicates that base pairs in 
enriched sequences are built up from A/U rather than G/C.  
All other analyzed structure features have Pearson correlation 
coefficients below 0.2 (-0.2), which are considered as not significant 
(Figure 3.19. and 3.20.). Therefore, no further interpretations could 
be made on the secondary structure of putative RLR ligands. 
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Figure 3.19. RNA secondary structure analysis of RIG-I-associated RNA. Heatscatter plots 
show the correlation between the analyzed parameters of RLR-associated sequences and the 
mean coverage of sequencing reads. (A) Mean read coverage of (+) RNA. (B) Mean read 
coverage of (-) RNA. 
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Figure 3.20. RNA secondary structure analysis of MDA5-associated RNA. Heatscatter plots 
show the correlation between the analyzed parameters of RLR-associated sequences and the 
mean coverage of sequencing reads. (A) Mean read coverage of (+) RNA. (B) Mean read 
coverage of (-) RNA. 
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Based on the literature, dsRNA like poly (I/C) is the only known 
agonist for MDA5 so far (Takeuchi and Akira, 2010). If this in vitro 
data would reflect the real situation in a virus-infected cell, a much 
higher correlation between the number of base pairings and the mean 
read coverage would be expected. Thus, it is speculated that double-
strand regions in vRNA are not sufficient to characterize an RNA 
molecule as a putative PAMP for the receptor protein. All together, the 
data indicate that RIG-I and MDA5 recognizes A/U-rich sequences 
partially forming double-stranded regions in a higher-order RNA 
structure. 
 
 
3.5. In vitro analysis of MeV RNA: confirmation of the NGS 
data 
 
The bioinformatical analysis of NGS data suggests a possible role of 
the A/U composition in the activation of RLR signaling. To further 
proof this hypothesis, 17 in vitro transcripts (IVTs) were generated 
covering different regions of the MeV genome representing 200 nt long 
RNAs of positive polarity (section 2.1.5.).  
As a first step, the immunostimulatory activity of RNA transcripts was 
validated. The results reveal that high copy numbers from NGS 
libraries correlate with the stimulatory activities of IVTs (Figure 3.21. 
and 3.22.). According to the immunostimulatory experiment, increased 
immune stimulation is observed for transcripts 9 and 12 (Figure 
3.21.). Interestingly, transcript 9 exactly corresponds to those regions 
at the 5’ end of the L gene, which contain the highest copy numbers of 
(+) RNA in the RLR libraries (Figure 3.7.). In general, it appears that 
IVTs representing regions within the L gene have higher 
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immunostimuatory activities in comparison to the upstream genomic 
segments. This is in good agreement to the NGS data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
F 
 
 
Furthermore, calculated Pearson correlations indicate that the best 
correlation between maximal numbers of sequencing reads and the 
immunostimulatory activity of RNA transcripts is observed for MDA5 
sequencing data (cor = 0.526), while RIG-I and GFP samples show less 
correlation (cor = 0.369 and cor = 0.217) (Figure 3.22. A). 
In order to find a possible explanation for the different 
immunostimulatory potentials of IVTs, the transcripts were analyzed 
in silico (RNAfold). The obtained data reveal that the 
immunostimulatory potential strongly correlates with the A/U content 
of IVTS (cor = 0.599) (Figure 3.22. C), which is consistent with 
bioinformatical data from the NGS experiment (see section 3.4.4.). 
Visualization of the transcripts on the Agilent bioanalyzer RNA chip 
Figure 3.21. Analysis of in vitro transcribed RNA of the measles virus genome. Sequences 
were generated according to the NGS data. The transcripts were either transfected into 293T 
ISRE-FF/RFP cells in order to validate the immunostimulatory potential or ATPase hydrolysis 
experiments were performed in the presence of recombinant mMDA5. Comparison of luciferase 
activities (black) and relative ATPase activities (grey) of in vitro transcribed RNAs (n=3 and 
n=2) are shown here. Highest values were set to 1. In the case of immunoactivity experiments, 
highest stimulation is observed for transcripts number 9 and 12. Surprisingly, the ATP 
hydrolysis rate by mMDA5 is highest for transcript 1, 3, and 7, which show remarkably less 
immunostimulatory potential. 
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indicates that no higher-order structures due to the sequence 
composition are formed that might explain differences in 
immuostimulatory activity (data not shown). Taken together, the data 
allow speculating that the A/U content of sequences causes differences 
in immunostimulatory potentials of the tested transcripts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Finally, a possible correlation between the ATPase hydrolysis activity 
of MDA5 and the immunostimulatory potential of IVTs was 
investigated. Therefore, the ATP hydrolysis rate of recombinant mouse 
Figure 3.22. Analysis of in vitro transcribed RNA of the Measles virus genome. (A) Pearson 
correlation between (+) RNA maximal coverage and the relative luciferase activity. (B) 
Pearson correlation between (+) RNA maximal coverage and the relative ATPase activity. (C) 
Correlation analysis between the AU content and the luciferase or ATPase activity, and 
between the ATPase activity and the luciferase activity. 
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MDA5 in the presence of RNA transcripts was tested (Figure 3.21. 
and 3.23.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.23. ATPase activity assay. mMDA5 was incubated with the respective IVT in the 
presence of ATP. The reaction was incubated over a time course of 1 h. Free phosphate was 
separated by thin layer chromatography (TLC) and visualized on a phosphorimage screen. The 
ATPase hydrolysis rate was determined by quantifying free phosphate at 15 min after adding 
ATP to the reaction mix. IVTs 1, 3, and 7 strongly stimulate ATP hydrolysis by mMDA5, as it 
is shown by the release of 32P. As a control, mMDA5 was stimukated with poly (I/C). 
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According to the data, the highest ATP hydrolysis rate is observed for 
transcripts 1, 3, and 7 (Figure 3.23.), which show remarkably less 
immunostimulatory activity in comparison to transcript 9 and 12 
(Figure 3.21.). The results further indicate a negative correlation 
between the maximum numbers of sequencing reads in the MDA5 
library (cor = -0.414) and the ATP hydrolysis rate (Figure 3.22. B). 
Bioinformatical analysis of the in vitro data reveal that A/U-rich 
sequences lead to a decrease in ATP hydrolysis activity of MDA5 (cor = 
-0.445). Furthermore, the ATP hydrolysis rate negatively correlates 
with the immunostimulatory activity of RNA transcripts (cor = -0.426) 
(Figure 3.22. C). These results suggest that the ATPase hydrolysis 
activity of MDA5 interferes with the immunostimulatory potential of 
the RNA transcripts and could therefore provide a first model of RNA 
recognition by the receptor protein (discussed in section 4.8.). 
 
 
3.6. Investigation of RNase L cleavage sites: Towards a 
rational model 
 
The observed correlation between the mean coverage in RLR libraries 
and the A/U composition in RNA sequences, raises the possibility of a 
potential role for RNase L in the processing of RNA species during 
MeV infection. RNAse L is an endoribonuclease, which is widely 
expressed in a variety of mammalian tissues (Zhouh et al., 2005), 
existing as a monomer in the uninfected state. Several studies showed 
that the enzyme is activated upon viral infection by the production of 
2’5’-oligoadenylate (2’5’A) molecules that bind to RNase L and lead to 
its dimerization (Chakrabati et al., 2011; Luthra et al., 2011). The 
activation of the enzyme is believed to take place in a second round of 
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antiviral signaling. Initial recognition of the virus leads to the 
activation of oligoadenylate synthetases (OAS), which produce 2’5’A 
molecules, required for RNase L activation (Figure 3.24.). Activated 
RNase L is suggested to cleave cytosolic RNA at A/U-rich sequences in 
single-stranded regions, thereby generating RNA species that could 
fold into potent PAMPs for RIG-I and MDA5 proteins (Malathi et al., 
2010; Malathi et al., 2007; Washenber at al., 2007). This feedback loop 
could represent the secondary response against an invading virus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To investigate the role of RNase L in RLR signaling, the MeV genome 
was divided into fragments of 500 nucleotides and folded in silco using 
RNAfold with the standard parameter settings. The folded fragments 
were then analyzed for potential RNase L cleavage sites in single-
Figure 3.24. Potential model of the OAS/RNase L pathway in antiviral signaling. Initial virus 
sensing occurs via RIG-I, which transduces the signal to a MAVS-dependent signaling cascade 
leading to the expression of type I interferons. This in turn leads to the expression of 
interferon stimulated genes (ISG), including oligoadenylate synthetases (OASs). In the 
presence of dsRNA, OAS synthesizes 2’5’A molecules from ATP that bind to and activate the 
enzyme RNase L. Activated RNase L cleaves cytosolic RNA species at single-strand A/U-rich 
regions, generating RNA molecules that serve as ligands for RIG-I and MDA5. This second 
round of signaling enhances the antiviral response (adapted from Malathi et al., 2010). 
(adapted from Malathi et al., 2010). 
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stranded regions (Han et al., 2004). Comparison of cleavage sites with 
the 
NGS data (see section 3.2.1.)  
 
 
Figure 3.25. Analysis of putative RNase L cleavage sites. Grey: Number of respective RNA 
cleavage site in an in silico folded RNA fragment with the size of 500 nucleotide. Red, blue: 
Sequence copy numbers of RIG-I and MDA5 libraries. 
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stranded regions (Han et al., 2004). Comparison of cleavage sites with 
the NGS data (see section 3.2.1.) indicates that some of the analyzed 
sequences correlate with the copy numbers of RLR libraries (Figure 
3.25.).  
Especially, the sequences -UUAA-, -AUUU-, and -UUUA- nicely 
overlap with the NGS data. Furthermore, analysis of cleavage sites 
indicates that no particular cleavage site perfectly fits to the sequence 
distribution, suggesting that several RNase L recognition sites might 
contribute to the observed sequence distribution in the NGS libraries. 
In conclusion, the data principally allow raising the hypothesis of a 
potential role of RNase L in RLR ligand generation. 
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4. Discussion 
 
4.1. PAR-CLIP: A promising tool to study RLR agonists? 
 
Aim of this thesis was to characterize in vivo occurring RNA ligands 
for RLR proteins. Therefore, a method was established, which was 
previously described as the PAR-CLIP methodology (Hafner et al., 
2010). In this approach photoactivatable nucleoside analogs are 
applied to live cells and a covalent linkage between the RNA ligand 
and the RNA-binding protein is induced upon 365 nm UV exposure. 
Due to the utilization of 4SU, Hafner and colleagues observed 
prominent transitions from T to C at the interaction sites of the RNP 
complexes, facilitating the identification of binding sites by mutational 
analysis. Compared to regular 254 nm UV crosslinking in the absence 
of photoactivatable nucleosides, PAR-CLIP yields higher RNA recovery 
levels and the usage of lower energy wavelength holds the advantage 
of a more specific crosslink and hence to less unspecific RNA, which is 
co-purified upon immunopurification of the respective protein (Hafner 
et al., 2010). 
To validate the approach, a line of initial experiments were performed 
to analyze the 4SU incorporation efficiency into viral RNA and to 
compare the RNA recovery levels between crosslinked and non-
crosslinked immunoprecipitates. An important requirement for using 
the method was to proof the incorporation of photoactivatable 
nucleoside analogs into viral RNA. Figure 3.1. displays the 4SU 
incorporation levels obtained by (q)PCR analysis. The data suggest 
that the nucleoside analog is indeed incorporated into viral RNA. 
However, the experimental set up does not allow a precise conclusion 
over the incorporation levels, since only two viral genomic segments 
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were investigated. Furthermore, no conclusion about the nature of 
analyzed RNA could be made. Although, the primers used for the 
experiment should give rise to (+) RNA species representing mRNA 
transcripts, it is possible that only one single antigenome was co-
purified and analyzed by (q)PCR. Comparison of incorporation levels 
between viral RNA and endogenous RNA indicates that large amounts 
of 4SU are incorporated into host RNA, suggesting a competition 
between viral and endogenous RNA for the photoactivatable nucleoside 
analog (Figure 3.1.). 
Next, PAR-CLIP was compared to a commonly used pull down 
technique (section 3.1.2.). The data show that treatment of cells with 
4SU and 365 nm UV exposure leads to an improved RNA 
copurification in comparison to the non-crosslinking strategy. 
Independent experiments indicate that the recovery levels increase 
between 20 to 50% depending on the experimental set up (Figure 3.2. 
C and 3.5.). However, RLR-associated RNA from crosslinking samples 
shows a reduced immunostimulatory potential in comparison to non-
crosslinked RNA (Figure 3.2. A). This observation raises the 
possibility that after protein digestion in the course of the experiment 
single amino acids or small polypeptide chains are still bound to 
nucleotides of the RNA that could interfere with the 
immunostimulatory effect of the molecule. 
Time- and dose-dependent experiments revealed that 4SU treatment 
does not interfere with cell viability or viral replication (Figure 3.3. 
and 3.4.). Based on the initial findings, following parameters were 
chosen for the experimental set up. For infection experiments, A549 
cells were treated with virus at a MOI of 1.0 in the presence of 400 µM 
4SU. To ensure that viral replication and transcription is fully 
activated at the time of UV crosslinking, infection was allowed to occur 
for 24 hours. However, at this time point a decrease in endogenous 
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protein levels was observed indicating that cells were already seriously 
affected by viral infection (Figure 3.4. B).  
 
 
4.2. Validation of immunostimulatory activity of RLR-
associated RNA 
 
To validate the immunostimulatory potential of RLR-associated RNA, 
293T ISRE FF/RFP cells were transfected with co-purified RNA from 
RLR immunoprecipitates. The reporter gene read out allows 
speculating to what extend the enriched molecules are specifically 
recognized by RIG-I or MDA5. Upon transfection of RNA, potent RLR 
agonists lead to activation of RLR signaling, resulting in type I 
interferon production. This in turn activates the reporter gene 
expression via STAT/STAT signaling. However, a positive read out 
does not necessarily indicate a direct interaction between the receptor 
proteins and the transfected RNA. It is also possible that an indirect 
interaction, with additional steps involving unknown interaction 
partners, activates the reporter gene expression. Nevertheless, the 
reporter cell system is an established approach to investigate RLR-
associated RNAs. 
As shown in Figure 3.6., immunostimulatory RNA was obtained from 
RIG-I and MDA5 immunoprecipitates of MeV-infected cells. The 
induction was significant in comparison to the negative control. 
Consistent with the literature, RIG-I-associated RNA shows increased 
immunostimulatory activity in comparison to MDA5-associated RNA, 
suggesting a major role for RIG-I in the immune response against MeV 
infection (Plumet et al., 2010). Measles belongs to the family of 
Paramyxoviridae, which encode for a non-structural protein V. This 
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protein is known to inhibit RLR signaling at various levels including a 
direct interaction with the DExC/H box helicase domain of MDA5 
(Motz et al., 2013). The inhibitory binding of V protein could interfere 
with RNA binding and hence explains the reduced immunostimulatory 
activity of RNA from MDA5 immunoprecipitates (Figure 3.6.).  
In regard to other viruses, co-purified RNA from RLR proteins was not 
capable to induce an immune response, which highlights the 
differences in viral replication cycles (Figure 3.6.). In fact, 
picornaviruses like EMCV and Mengo would be the preferred viral 
species to study endogenous MDA5 agonists (Loo et al., 2008). 
However, EMCV has a higher pathogenicity in comparison to MeV, 
which under the given conditions lead to dramatic cell death after 24 
hours. Reduction of the infection time is not recommended, since the 
protein levels for MDA5 would also decrease, directly affecting the 
levels of co-purified RNA. In the uninfected state, cells express basal 
levels of MDA5, which become strongly up-regulated in the course of 
an infection. To ensure suitable amounts of MDA5 protein at the time 
of in vivo crosslinking, viral infection was therefore allowed to occur for 
24 hours. To study EMCV-derived RNA ligands for MDA5, it is 
possible to express recombinant MDA5 prior to virus infection. This 
would ensure high levels of protein already at early stages of infection 
and would allow a reduction in infection time. However, overexpressed 
MDA5 is capable to induce an antiviral state, even in the absence of 
viral infection (Crampton et al., 2012; unpublished data), which could 
interfere with viral replication. 
In conclusion, the established protocol was suitable to study RLR-
associated RNAs from MeV-infected cells. However, the PAR-CLIP 
approach has to be adapted and modified for each viral infection.  
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4.3. Identification of RLR-associated RNA from MeV-
infected cells using Next generation sequencing (NGS) 
 
 As already mentioned in section 3.2.1., the NGS technology offers 
numerous advantages to study RNA-protein interaction networks in 
comparison to commonly used techniques. Studying RNA species by 
NGS does not require any prior assumptions about the molecule to be 
investigated. In addition, the redundancy of specific primers reduces 
the likelihood of introducing artifacts and allows an unbiased analysis 
of the molecules of interest.  
 In this work, the co-purified RNA from RLR and GFP samples was 
processed into cDNA libraries. Based on constraints of the sequencing 
technology, the RNA was subjected to random fragmentation prior to 
cDNA synthesis (see section 2.3.2.). This was necessary, since longer 
RNA would interfere with the efficiency of bridge amplification and 
cluster formation in the Illumina NGS approach. Consequently, the 
obtained NGS data do not allow any conclusions about the possible size 
of the putative RNA ligands, or about the 5’ and 3’ ends of co-purified 
RNA species.  
 A major problem for NGS analysis is the high background of 
unspecifically co-purified RNAs from immunoprecipitates. The most 
prominent RNA species, which are commonly found in 
immunoprecipitates are of ribosomal origin. High levels of background 
RNA would interfere with the depth of analysis and should be removed 
from the RNA library. Therefore, an rRNA removal kit was used to 
enrich RLR-associated RNA. About 16% (RIG-I) and 7% (MDA5) of the 
total number of sequencing reads were uniquely mapped against the 
MeV genome, while the rest corresponded to endogenous RNA species.  
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Prior to the NGS run, the cDNA libraries were analyzed on an Agilent 
Bioanalyzer Chip array. This quality control was done to ensure that 
the libraries had a sufficient concentration and were properly 
fragmented into shorter RNA species.  
After running the libraries on the Illumina Genome Analyzer, the 
obtained sequences were processed in order to remove adapter 
sequences and reads with PHRED scores below 30. PHRED quality 
scores are defined as a property, which is logarithmically related to the 
base-calling error probabilities (Ewing and Green, 1998). A PHRED 
score of 30 represents a base call accuracy of 99.9%. The remaining 
sequences were mapped to human and viral genomes, allowing 
maximal one mismatch per unique read. These filter steps guaranteed 
high quality sequencing reads that could be further analyzed. 
NGS data of RLR-associated RNA revealed that RIG-I and MDA5 bind 
to same regions within the L genomic segment. In addition, RIG-I, but 
not MDA5, binds to the 3’ and the 5’ ends of the MeV genome. These 
regions probably represent leRNA or trRNA generated in the course of 
replication (Figure 3.7.). Separation of (+) and (-) RNA furthermore 
indicated that MDA5 exclusively enriches MeV RNA of positive 
polarity. This is a remarkable difference in comparison to RIG-I, where 
high copy numbers are observed for both (+) and (-) RNA (Figure 3.8.). 
The data evidently rules out the possibility that MDA5 recognizes RNA 
duplexes of (+) and (-) RNA that might represent replication 
intermediates as previously described (Feng et al., 2012). The result 
rather suggests that MDA5 binds (+) RNA corresponding to mRNA or 
MeV antigenome. 
Since MDA5 obviously does not bind (-) RNA, which corresponds to the 
MeV genome, it is conceivable that (+) RNA enriched by MDA5 most 
likely originate from mRNA species of the L genomic segment, rather 
than antigenomic sequences. The antigenomic RNA is generated 
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during replication in order to synthesize a template for the genomic 
strand. Like the genome, the antigenome is subsequently packed into 
nucleocapsids after replication, where they are inaccessible for 
cytoplasmic proteins (Blumberg et al., 1981; Bitko and Barik, 2001). 
Hence, genome and antigenome should not be considered as RNA 
ligands for RLR proteins.  
In addition to recognizing (+) RNA of the L gene, RIG-I also binds to 
RNA of positive polarity originating from the 3’ end of the MeV 
genome, starting at the leader region. Analysis of these sequences by 
qPCR indicates that the molecules could comprise leRNA-N read-
through transcripts or abortive replication products that could include 
5’ triphosphate ends (Figure 3.11 A). Consequently, these RNA 
molecules could act as putative RNA ligands for RIG-I. In regard to 
RNA of negative polarity, RIG-I binds to regions comprising the trailer 
region and the L genomic segment. It might be possible that these 
RNA species represent abortive replication products of the antigenomic 
replication process that lead to short RNA molecules comprising 5’ 
triphosphate ends (Cattaneo et al., 1987). 
A closer look to the sequencing distribution between RLR and GFP 
samples revealed that the pattern of enriched sequences is similar 
between the samples. This raised the question whether the observed 
sequences in RLR libraries are indeed specific ligands for the receptor 
proteins. To address this question CNV data were generated that 
clearly show specific enrichment of RNA in the main peaks of the RLR 
libraries (Figure 3.9. and 3.10.). The similarity in the sequence 
enrichment pattern between control and RLR samples is a commonly 
observed phenomenon in NGS libraries. An explanation for this may be 
the introduction of a small bias due to the protocol used for cDNA 
synthesis. However, immunostimulatory experiments and CNV data 
clearly indicate that the enriched sequences specifically interact with 
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RLR proteins (Figure 3.7. and 3.9. and 3.10). Furthermore, if an 
unspecific enrichment of MeV RNA due to higher abundances of 
certain RNA species were expected, one would observe a decreasing (+) 
RNA gradient from the N genomic segment to the L gene (Cattaneo et 
al., 1987) (see section 1.3.). This was apparently not the case. 
 
 
4.4. Quantitative (q)PCR analysis generally confirms NGS 
data  
 
NGS data were generally confirmed by (q)PCR analysis (Figure 3.11.). 
However, the results do not reflect all RNA sequences analyzed by 
NGS. For (q)PCR, primer pairs were used corresponding to short areas 
of the 3’ ends of MeV mRNA transcripts. Therefore, the analysis 
excludes any investigation of enriched (-) RNA. Furthermore, the 
different primer pairs gave rise to PCR products varying between 150 
and 200 nucleotides in length, which could also influence the 
amplification of the respective genomic region. Differences in 
annealing temperatures of primers did not allow performing the 
(q)PCR with an optimized amplification protocol. Therefore, a direct 
comparison between the different genomic segments is rather 
unreliable. The obtained copy numbers for each genomic segment were 
normalized to GFP and copy numbers from RIG-I and MDA5 samples 
were compared. Although this superficial analysis does not allow 
precise conclusions, the NGS data was in general confirmed showing a 
sequence enrichment of (+) RNA towards the 3’ end of the MeV genome 
(Figure 3.11. A). 
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4.5. Bioinformatical analysis of NGS data 
 
4.5.1 Analysis of transition frequencies in the NGS data 
 
One major advantage of PAR-CLIP is the introduction of specific 
transition from T to C in NGS libraries. The identification of these 
transitions by mutational analysis can be used to assign the direct 
binding sites of the RNP in RNA molecules.  
To determine interaction sites between viral RNA and RLR proteins, 
the frequency of all possible transitions was investigated (Figure 
3.12.). The mutational analysis indicates that T to C conversions do not 
occur with a significant higher frequency in comparison to other 
mutations. In fact, the highest frequency is observed for G to T 
transversions in (+) RNA of RIG-I libraries. Since crosstalk phenomena 
are unlikely to cause the observed transversions (see section 3.4.1.), it 
seems conceivable that the observed mismatches represent the correct 
nucleobases in the sequencing reads. It is possible that errors were 
introduced into the RIG-I library during cDNA preparation that could 
have led to the transversion from G to T.  Comparison between the 
RLR libraries and the control shows that transitions occur at similar 
rates in relation to the copy numbers of sequencing reads (Figure 
3.12.). In regard to MDA5 and GFP, conversions from T to C have a 2-
fold higher frequency in comparison to the second most common 
transition (A to G) (Figure 3.12. B, C). However, this slight increase 
in T to C is considered to be not significant. The observed T to C 
transitions either occur in 100% percent of the sequencing reads 
(Figure 3.13. A) at a particular transition site, or have an occurrence 
below 5% (Figure 3.13. B). Both cases indicate that the observed T to 
C mutations do not result from specific crosslinks, but rather originate 
from wrongly annotated nucleobases or background transitions from 
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non-crosslinked 4SU residues. Furthermore, mismatches that occur to 
a few percent in the sequencing read counts could represent errors, 
which were introduced in the sequencing process. 
Possible reasons for the lack of prominent transitions from T to C are 
numerous. In fact, it could be possible that due to the experimental set 
up the incorporation of 4SU into viral RNA is rather inefficient and 
endogenous RNA strongly competes for the photoactivatable nucleoside 
analog (Figure 3.1.). Endogenous RNA is synthesized in the nucleus, 
while MeV replication and transcription exclusively takes place in the 
cytosol (Gerlier and Lyles, 2011). If the nucleus were the preferred 
compartment for incorporation of 4SU into newly synthesized RNA, 
vRNA would have a significant disadvantage towards endogenous 
RNA, resulting in poor 4SU incoporation levels. According to Hafner 
and colleagues only one uridine out of 25 is substituted by 4SU, further 
emphasizing the inefficiency of 4SU incorporation (Hafner et al., 2010).  
Furthermore, it is also thinkable that 4SU is efficiently incorporated 
into vRNA, but the crosslinking rates are too low to result in 
prominent T to C transition levels. A major disadvantage of PAR-CLIP 
in regard to this project is that RLR proteins recognize vRNAs forming 
higher-ordered structures with partially dsRNA regions. The relative 
inefficient crosslinking of extended regions of dsRNA could lead to a 
further decrease in the T to C conversion rate to a level, where these 
mutations could not be distinguished from background mutations.  
Therefore, the arising question is what caused the improved recovery 
levels of RLR-associated RNA from MeV-infected cells? In regard to 
this thesis, the applied doses of 365 nm UV light were up to 10-fold 
higher in comparison to the original PAR-CLIP protocol (Hafner et al., 
2010). Consequently, this could result in an unspecific crosslink of 
unmodified nucleosides as observed for 254 nm UV crosslinking 
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approaches (Meisenheimer and Koch, 1997) and to an enrichment of 
RLR-associated RNA. 
 
4.5.2. Does the MeV genome contains sequence motifs that are 
recognized by RLR proteins? 
  
 Since the mutation analysis did not allow to draw any conclusions 
about preferred binding sites of the receptor proteins, the nucleotide 
composition of enriched sequences was further investigated. 
 For this, the base content of the MeV genome was set into correlation 
with the mean read coverage of RIG-I and MDA5 libraries in a shifting 
window of 10 nucleotides (Figure 3.14. and 3.15.). In addition, all 
occurring 5-mers were analyzed in regard to a possible correlation with 
the median read coverage of the RLR libraries (Figure 3.16. and 
3.17). Theses analyses were done in order to investigate whether the 
viral genome comprises any nucleotide bias or any sequence motifs 
that might explain the mechanism of recognition by RLR proteins.  
The data led to the conclusion that according to the converging 
medians and notches in the represented boxplots, a possible nucleotide 
bias could not be the explanation for the read coverage in the RLR 
libraries (Figure 3.14. and 3.15.).  
The 5-mer analyses revealed that the broad majority of investigated 5-
mers do not show any enrichment in comparison to the expected 
values. However, based on the data, one could speculate that a slight 
correlation is observed for A/U-rich 5-mers, since these sequences show 
a slightly higher median in comparison to the expected ones (Figure 
3.16. and 3.17.).  
Taken together, the data rule out the possibility of a sequence motif in 
the viral genome that explains the recognition of vRNA by RLR 
proteins. In principle, it should be discussed to what extend a sequence 
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motif would make sense for the virus. A conserved motif, which is 
recognized by the innate immune system, would represent a crucial 
disadvantage for the virus to survive and successfully replicate in the 
host cell. Furthermore, viruses have rather imprecise replication 
machineries introducing frequently point mutations in their genome, 
thereby successfully adapting to new environmental challenges. A 
possible binding motif in the viral genome would have been lost over 
viral evolution by constantly introducing point mutation in every viral 
life cycle. Therefore, it seems more conceivable that recognition of viral 
RNA depends on other features, including secondary structures or 
possibly a combination of both. 
 
4.5.3  RNA secondary structure analysis 
  
 As discussed above, a simple binding motif is not sufficient for efficient 
recognition by RLR proteins. To validate a possible contribution of 
secondary structures in vRNA to the activation of RLRs, the MeV 
genome was subjected to RNA secondary structure prediction.  
 The Pearson correlation coefficients were calculated for a variety of 
RNA secondary structure parameters and the mean read coverage of 
the RIG-I and MDA5 libraries (Figure 3.19. and 3.20.). The Pearson 
correlation coefficient is a measure for the linear relationship between 
two variables. A Pearson correlation coefficient of 0 means that there is 
no linear correlation and a correlation of ± 1 declares a perfect positive 
or negative linear relationship (Upton and Cook, 1996). In this work, a 
Pearson correlation coefficient above/below ± 0.2 was considered as 
reliable. The results indicate that the majority of analyzed parameters 
do not correlate with the mean read coverage in the RLR libraries. 
However, slight correlations are observed for the A/U content and the 
number of base pairs in the NGS samples (Figure 3.19. and 3.20.).  
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When discussing in situ data, one should note that the approach of 
RNA secondary structure prediction is highly artificial and most likely 
does not reflect the real conditions in vivo. For this analysis, the 
genome was divided into fragments of 201 nucleotides. These 
fragments were then folded using RNAfold (Vienna RNA package) and 
its standard parameter settings. Based on the folding, secondary 
structure parameters were set into correlation to the mean coverage of 
the NGS libraries. However, the length of 201 nucleotides for each 
analyzed fragment was chosen at random and the real ligand for the 
receptor proteins could either be shorter or longer. The length of RNA 
greatly influences the outcome of the in silico folding and therefore the 
data could differ depending on the size of the analyzed fragments.  
Moreover, one should note that in silico folding of RNA only represents 
a limited reflection of the real condition in the cell. Folding with 
RNAfold relies on base pairing probabilities and the minimum free 
energy of the isolated RNA sequence. However, in a living cell the RNA 
molecule may not exist as an isolated species but constantly interacts 
with numerous cytosolic factors including RNPs, which could influence 
the stability and the shape of the RNA. Thus, the RNA secondary 
structure should not be considered as a rigid formation but rather as a 
dynamic structure that may coexist with different formations in 
equilibrium. Those conditions are very difficult to take into account 
when analyzing RNA secondary structures in silico. To get a more 
reliable conclusion about possible RNA secondary structures in RLR 
ligands, a combination of in silico data and in vitro experiments could 
be applied. 
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4.5.4. Does the crosslinking approach introduce an A/U bias into the 
NGS data? 
 
Taken together, the bioinformatical analysis suggests that the A/U 
composition contributes to MeV RNA recognition by RLR proteins. The 
enrichment of sequences with a high A/U content by RLR 
immunoprecipitates raises the possibility of an experimental bias that 
is introduced due to the utilization of 4SU. The increased incorporation 
of 4SU into regions with a high A/U content would consequently lead to 
an increase in the crosslinking rate and to a preferred enrichment of 
those sequences. However, if this would be the case an enrichment of 
transitions from T to C should occur in A/U-rich sequences of NGS 
libraries. According to the mutational analysis (section 3.4.1.) 
increased transition frequencies from T to C are not observed, which 
therefore excludes the possibility of an A/U bias in the NGS data due to 
the crosslinking of 4SU. 
Another reason for a possible A/U bias in the enriched sequences could 
be the increased crosslinking dose. Beside photoactivatable nucleoside 
analogs, wild-type nucleobases themselves have photoreactive 
characteristics that are exploited in commonly used 254 nm UV 
crosslinking approaches. The optimum excitation wavelength for 
uridine is about 275 nm, while the remaining nucleosides show the 
maximum excitation between 250 and 265 nm (Meisenheimer and 
Koch, 1997). The range of the UV spectra of uridine raises the 
possibility that due to the higher optimum of the crosslinking 
wavelength, uridine residues become more readily excited upon 365 
nm UV exposure than other nucleobases. This would consequently lead 
to preferred crosslinking between uridine moieties and the amino acids 
of the interacting protein. Since crosslinked wild-type uridine does not 
result in specific transitions in the course of reverse transcription, it is 
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difficult to proof based on NGS data, whether this possibility should be 
taken into consideration. 
 
 
4.6. Confirmation of in vivo data by in vitro experiments  
 
 To proof the hypothesis of a possible role for A/U-rich sequences in 
RLR activation and to rule out the possibility of an A/U bias in the 
NGS data due to the experimental set up, in vitro experiments were 
performed. 
 For this, 200 nucleotide long in vitro transcripts were generated 
corresponding to different regions in the MeV genome. To ensure that 
remaining 5’ triphosphate moieties did not influence further analysis, 
transcripts were enzymatically double-dephosphorylated.  
Immunostimulatory experiments clearly revealed a correlation 
between the maximum coverage of RLR libraries and the 
immunostimulatory potential of the tested transcript (Figure 3.22. A). 
In addition, analysis of the in vitro data further showed that the 
immunostimulatory activities of RNA molecules strongly correlate with 
the A/U content of transcripts (Figure 3.22 C). This finding is in 
agreement with the bioinformatical data and evidently rules out the 
possibility that an A/U bias due to the experimental set up results in 
the observed RNA enrichment by RIG-I and MDA5. 
Prior to transfection into the reporter cells the transcripts were heated 
up to 90 ºC and cooled down either rapidly or by a slowly decreasing 
temperature gradient. By this, the influence of possible secondary 
structures for the immunostimulatory potential was investigated. 
However, no differences in the induction of reporter gene expression 
were observed, indicating that the immunostimulatory effect is indeed 
based on the sequence composition. This was also confirmed by 
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bioanalyzer data showing that all transcripts exist in one conformation 
representing a 200 nt molecule (data not shown). 
To elucidate the underlying mechanism of RLR activation by A/U-rich 
sequences, transcripts were incubated with recombinant MDA5 in the 
presence of ATP. Surprisingly, the observed ATPase activity by MDA5 
negatively correlates with the immunostimulatory activities of the 
transcripts. Bioinformatical analysis reveals an inverse correlation 
between the A/U content of sequences and the ATP hydrolysis rate of 
MDA5 (Figure 3.22. C). This finding obviously indicates that the 
ATPase activity of the protein interferes with the immunostimulatory 
potential of the RNA. 
 
 
4.7.  A possible role for RNase L in the generation of RLR 
agonists  
 
The question of the exact nature of RLR ligands from MeV- infected 
cells still needs to be elucidated. In fact, NGS data and in vitro 
experiments revealed that the A/U composition of viral RNA might 
contribute to RLR activation. However, nothing is known about the 
length or structure of the putative RLR agonists. 
Several studies in the past suggested a role of RNase L in the 
generation of RNA ligands for RIG-I and MDA5 (Han et al., 2004; 
Malathi et al., 2007; Luthra et al., 2011). The generated agonists can 
either be of viral or endogenous origin and are characterized by A/U-
rich cleavage sites for the enzyme. The finding of a possible correlation 
between A/U-rich sequences and the activation of RLR signaling, 
raised the question whether RNase L plays a role in the immune 
response against MeV infection. To address this, the genome was 
4. DISCUSSION 
	  
 
 
103	  
searched for the most prominent RNase L cleavage sites (Han et al., 
2004). Comparison with the sequencing coverage revealed that some of 
these recognition sites indeed nicely overlap with the enriched 
sequences of RLR immunoprecipitates (Figure 3.25.), suggesting a 
possible role of RNase L in the generation of RNA ligands for the 
receptor proteins. A recent work on parainfluenza virus 5 (PIV5) 
further supports this theory (Luthra et al., 2011). Like Measles, PIV5 
is a nonsegmented, negative-strand RNA virus belonging to the family 
of paramyxoviridae (Lamb and Kolakofsky, 2001). Robert Silverman 
and colleagues provided evidence that RNase L is involved in the 
cleavage of distinct region of the PIV5 L gene, leading to RNase L 
cleavage products that are capable to activate IFN expression in an 
MDA5-dependent manner (Luthra et al., 2011). This data is in good 
agreement with findings in this thesis and supports a possible role of 
an RNaseL-MDA5-dependent pathway in the immune response of MeV 
infection. 
However, the hypothesis is speculative and further experiments need 
to be done in order to draw reliable conclusion in regard to RNAse L 
and its role in RLR agonist formation. 
 
 
4.8. RLR-associated RNA is rich in A/U: A current working 
model 
 
 The results obtained by NGS experiments, in silico and in vitro 
approaches finally allows to set up a model to explain the possible 
mechanism of MeV RNA recognition by RLR proteins. 
 Based on the sequence distribution in NGS libraries (Figure 3.7.), the 
RNA species recognized by RLR proteins could be divided into two 
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classes. The first class would comprise RNA molecules originating from 
the 5’ triphosphate ends of the genome or antigenome. These molecules 
could be generated in the course of read-trough transcription and 
abortive replication (Cattaneo et al., 1987; Plumet et al., 2005) and 
could therefore represent preferred ligands for RIG-I, as already shown 
in previous work (Baum et al., 2010). The second class of RNA 
molecules could be recognized by both receptor proteins. The data 
suggest that recognition of these RNAs might occur through the A/U 
composition of sequences, which would define a new basis for 
recognition of non-self RNA (Schnell et al., 2012). In this context, a 
possible role of RNase L in RLR agonist generation still needs to be 
investigated. 
Furthermore, the data indicate that the main contribution of MeV 
recognition is taken by RIG-I, while MDA5 seems to play a minor role. 
It is possible that RIG-I initially recognizes leader-N read-through 
transcripts or abortive replication products containing 5’ tri-phosphate 
ends, which then lead to the activation of the signaling cascade. In a 
second round of recognition, up-regulated RIG-I and MDA5 recognize 
viral transcripts that are rich in A/U. Especially in regard to MDA5, 
the data provide evidence that the preferred ligand for the protein is 
an RNA comprising A/U-rich sequences. Furthermore, the inverse 
correlation between the immunostimulatory potential of RNAs and the 
ATP hydrolysis rate by MDA5 (cor = -0.445; Figure 3.22 C) raises the 
possibility that the ATPase activity might not be necessary for, or even 
interferes with the immunoactivity of RNA ligands. Although this 
observation disagrees with recent findings about the role of ATP 
hydrolysis in RIG-I oligomerization on 5’ triphosphate dsRNA (Patel et 
al., 2013; Peisley et al., 2013), it seems conceivable that MDA5 and 
RIG-I markedly differ in their mechanical activation and the mode of 
ATP hydrolysis. The presented data is supported by results suggesting 
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that MDA5 filament formation is abrogated in an ATP-sensitive 
manner. By electron microscopy (EM) analysis it was shown that 
MDA5 filaments disassemble in the presence of ATP indicating that 
ATP hydrolysis triggers the translocation of the protein along the 
dsRNA molecule, thereby interfering with downstream signaling 
(Peisley et al., 2011; Berke et al., 2012).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In light of the current data in the literature, one can hypothesize that 
binding of RNA to MDA5 activates the ATPase activity of the helicase 
domain, leading to a translocation of the protein along the RNA 
molecule. Upon reaching A/U-rich dsRNA stretches, MDA5 could bind 
Figure 4.1. Proposed model of MDA5 activation by AU-rich RNA molecules. Upon binding to 
RNA, MDA5 translocates along the molecule in an ATP-dependent manner. As soon as the 
protein reaches A/U-rich double-stranded stretches, MDA5 binds with higher affinity to these 
regions. This results in a reduced ATP turn over and a slow down in translocation velocity. 
Additional MDA5 molecules are recruited that lead to MDA5 filament fomation and to 
downstream signaling via MAVS. 
 
. 
!"#$
%&$'
!
"
#$
%&
'(
)*
+')
(
,-*
)&
+.
/*
,'.
)%
01
+.
/'
,2
3'+*41),%3.-4*,'.)%5%
!#67%'),1-*/,'.)
#@A
#"A%5%A'
8#9"":;"<=9"
##>#>
8
>
>
#
#
?
>
?
8 ?
#
>
8
?
8
#8
>>
##
?8?>
#
8
8
?
#>
?
?
8?
8#??
88
#
>
8
?
? #??8##??
#@A
#"A%5%A'
4. DISCUSSION 
	  
 
 
106	  
with a higher affinity to these regions, leading to a decrease in 
translocation velocity. This could allow a stronger interaction between 
the RNA and MDA5, which finally triggers a higher 
immunostimulatory signal via MDA5 filament formation (Figure 4.1.). 
Although, the exact mechanism of recognition and the role of RNase L 
in this complex arrangement of immune factors remains to be analyzed 
in more detail, the work provides a first insight into the molecular 
basis of RNA sensing by MDA5 and is a good starting point for future 
investigation.  
 
 
4.9.  Improvement of RNA-protein crosslinks using 
alternative methods 
 
Although the PAR-CLIP technology yields improved RNA recovery 
levels from RLR immunoprecipitates, the lack of prominent T to C 
transitions highlights the disadvantages of the method in regard to the 
investigation of RLR-associated RNAs from virus-infected cells. 
To improve the specific co-purification of putative RLR agonists 254 
nm UV crosslinking could be tested. The higher energy wavelength 
could result in a more efficient crosslink between dsRNA regions and 
the receptor proteins in comparison to the 365 nm UV strategy. 
Methods involving such a crosslinking step include CLIP (Ule et al., 
2003; Ule et al, 2005), HITS-CLIP (Licatalosi et al., 2008; Chi et al 
2009), and iCLIP (Konig et al., 2010 and 2011). 
In regard to the inefficiency of dsRNA crosslinking upon UV 
irradiation an alternative approach might be the utilization of 
methylene blue. Methylene blue is a dye, which intercalates into 
dsRNA and mediates RNA-protein crosslinking upon exposure to 
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visible light (Liu et al., 1996). However, the available data represent in 
vitro experiments and so far little is known about the uptake of 
methylene blue and its crosslinking efficiency in living cells. 
Another possible procedure, is based on formaldehyde crosslinking, 
which could result in a much more efficient crosslinking between the 
RNA and the receptor protein. However, this strategy is rather 
unspecific, since crosslinking is not restricted to direct interaction 
partners but also occurs between unspecific molecules in close 
proximity. Furthermore, this in vitro method requires the co-
purification of RNA in stable RNA-protein complexes. Especially in 
regard to MDA5 and its transient interaction with its putative RNA 
ligands, the approach could be limited and could at best serve as a 
reference experiment. Currently, UV crosslinking techniques are under 
way (Ule lab) that are specifically developed to study dsRNA ligands. 
These new approaches might facilitate the analysis of RLR-associated 
RNAs and circumvent the limitations of conventional UV-crosslinking 
protocols as discussed in this thesis. 
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5. Summary 
 
The innate immune system provides the first line of defense against 
invading pathogens. Innate immunity relies on germline-encoded 
pathogen-recognition receptors (PRRs) that sense invariant molecular 
patterns of microbial origin, thereby triggering a fast but non-specific 
immune response. Cytosolic sensing of RNA viruses is mainly 
performed by the RIG-I-like receptors (RLRs) RIG-I, MDA5, and LGP2, 
which are helicase-like proteins sharing structural similarities. RLRs 
recognize viral infection to initiate and modulate an antiviral immune 
response. Upon binding of RNA molecules, which are absent from the 
uninfected host, the sensor proteins activate a MAVS-dependent 
signaling cascade, which leads to the expression of type I interferons 
(IFNs) and proinflammatory cytokines.  
One remaining question in the field is, how RLR proteins are able to 
distinguish between RNA from the uninfected and infected cell. In the 
past decade extensive efforts were made to characterize the exact 
nature of RNA agonists of RLR proteins. In vitro and transfection 
studies identified 5’ triphosphate containing double-strand (ds)RNAs 
as preferred ligands for RIG-I. In case of the RIG-I paralogs MDA5 and 
LGP2, the nature of RNA ligands is less well understood. Several 
studies suggest MDA5 as a simple dsRNA sensor in the cytosol. 
However, the experimental evidence for this is not conclusive, because 
the data mainly rely on in vitro transfection experiments that bring 
only limited and potentially misleading information about the 
physiological MDA5 agonist. To elucidate the exact nature and origin 
of RLR ligands, it is important to isolate and investigate RLR-
associated RNA from virus-infected cells. A major challenge in regard 
to examining MDA5 agonists is the apparently transient interaction 
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between the protein and its RNA ligands. To improve the stability of 
interaction between RNA and MDA5, a UV crosslinking approach was 
established, in which virus-infected cells are treated with the 
photactivitable nucleoside analog 4 thiouridine (4SU). Upon 365 nm 
UV exposure of living cells, a covalent linkage between the 4SU-
labeled RNA and the receptor protein is induced. This crosslink results 
in a higher RNA recovery from immunoprecipitates. Based on Next 
generation sequencing, bioinformatical analysis, and in vitro 
approaches, a correlation between the A/U-composition of viral RNA 
and its ability to induce an MDA5-dependent immune response was 
observed. The results suggest that RIG-I and MDA5 recognize A/U-rich 
RNA species, originating from the mRNA of the measles virus L gene. 
Interestingly, the immunostimulatory potential of A/U-rich RNA 
interferes with the ability to stimulate ATP hydrolysis by MDA5. 
Together with data in the literature, the results suggest that binding 
of RNA to MDA5 activates the ATPase activity of the helicase domain 
leading to translocation of the protein along the RNA molecule. The 
negative correlation between A/U-rich sequences and the ATP 
hydrolysis rate indicates that A/U-rich RNA could bind to MDA5 with 
a higher affinity than sequences rich in GC. This would lead to a 
decrease in translocation velocity and consequently to a stronger 
interaction between AU-rich RNA and MDA5, which then induces a 
higher immunostimulatory signal. At this stage, further analysis is 
required to confirm the model. Nevertheless, the work of the thesis 
provides a first insight into the molecular basis of RNA sensing by 
MDA5 and is a good starting point for future investigation of questions 
how recognition of viruses by RLRs is achieved. 
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